January 1 2 
— 1 3 4 5 6 
mutation 1 
undercut 1 
immune 1 3 4 7 
response 1 3 4 5 8 9 
COVID 1 8 
virusA 1 
handful 1 
SARS-CoV-2 1 2 3 4 5 6 7 9 
help 1 2 3 5 
escape 1 
mount 1 
subset 1 
infected 1 2 4 
people.Researchers 1 
identify 1 2 3 4 9 
thousand 1 
sample 1 2 4 5 9 
vast 1 
majority 1 5 7 
unlikely 1 4 
much 1 8 
effect 1 2 3 4 5 8 9 
virus 1 2 3 4 5 6 
’ 1 2 3 4 5 6 
biology 1 
potentially 1 2 8 9 
important 1 2 4 5 9 
Jesse 1 
Bloom 1 
Fred 1 
Hutchinson 1 
Cancer 1 3 
Research 1 4 5 9 
Center 1 5 
Seattle 1 
Washington 1 
colleague 1 9 
study 1 2 3 4 5 7 8 9 
antibody 1 2 3 4 5 7 9 
isolate 1 
blood 1 2 3 9 
serum 1 2 4 7 9 
people 1 6 8 
recover 1 2 4 5 9 
COVID-19 1 2 3 7 8 9 
A. 1 2 6 
J. 1 
Greaney 1 
al 1 
Preprint 1 
bioRxiv 1 
http 1 
//doi.org/ghr85d 1 
team 1 2 4 9 
test 1 2 3 4 5 6 7 9 
spike 1 2 4 5 9 
protein 1 2 4 5 9 
carry 1 7 
different 1 2 3 7 8 9 
version 1 3 4 5 9 
region 1 2 3 7 
call 1 
receptor 1 3 5 9 
bind 1 5 9 
domain 1 4 5 9 
RBD 1 9 
recognize 1 
host 1 7 
cell 1 4 5 9 
major 1 4 5 
target 1 2 4 5 9 
antibodies.Of 1 
reduce 1 2 3 4 5 8 9 
ability 1 
tightly 1 
change 1 4 5 6 9 
also 1 2 3 4 5 6 7 8 9 
indicate 1 3 4 5 6 9 
reduction 1 2 3 4 5 9 
disable 1 
virus.But 1 
vary 1 3 5 6 
substantially 1 4 5 8 
consequential 1 
location 1 
E484 1 
cause 1 2 3 5 6 7 9 
steep 1 
drop 1 
potency 1 
individual 1 2 4 7 8 9 
Coronavirus 1 2 3 5 9 
variant 1 5 
South 1 3 
Africa 1 3 
Brazil 1 3 
spot.The 1 
finding 1 2 4 5 7 9 
yet 1 3 4 5 9 
peer 1 
reviewed.12 1 
Immune 1 
go 1 
wild 1 
tie 1 
lung 1 5 7 9 
damageSome 1 
severe 1 2 3 4 5 7 9 
respiratory 1 2 3 4 5 7 9 
symptom 1 2 3 4 5 7 8 9 
seem 1 8 
result 1 2 3 4 5 6 7 9 
activity 1 4 7 9 
specific 1 2 3 5 
long-term 1 2 4 9 
inflammation 1 
lungs.Alexander 1 
Misharin 1 
Northwestern 1 5 
University 1 5 
Evanston 1 
Illinois 1 
examine 1 2 3 4 5 
fluid 1 
pneumonia 1 3 7 9 
infection 1 2 3 4 5 7 8 9 
R. 1 2 
A 1 2 9 
Grant 1 
et 1 
Nature 1 
//doi.org/fqds 1 
Most 1 2 4 5 
high 1 2 3 4 5 6 7 8 9 
number 1 2 3 4 5 7 8 9 
certain 1 4 
type 1 2 3 4 
T 1 
class 1 8 
researcher 1 5 9 
find 1 3 4 7 8 9 
nearly 1 9 
% 1 2 3 4 5 6 7 8 9 
alveolar 1 
macrophage 1 
locate 1 
tiny 1 
air 1 2 3 5 
sac 1 
contain 1 4 5 
harbour 1 
show 1 2 3 4 5 7 9 
relatively 1 
expression 1 
gene 1 5 
involve 1 2 3 4 5 
inflammation.The 1 
suggest 1 2 3 4 5 7 9 
reach 1 2 3 5 
infect 1 2 4 
respond 1 
produce 1 
inflammatory 1 3 9 
molecule 1 
attract 1 
turn 1 8 
stimulate 1 
make 1 4 9 
persistent 1 2 9 
lead 1 3 4 5 8 
life-threatening 1 2 5 
consequence 1 9 
infection.11 1 
Traitorous 1 
link 1 5 
deathAntibodies 1 
normally 1 
attack 1 
pathogen 1 8 
sometimes 1 8 
rogue 1 
instead 1 6 
besiege 1 
bodily 1 
component 1 4 
Now 1 
new 1 2 3 4 5 8 9 
add 1 3 8 
grow 1 
body 1 3 
research 1 3 
‘ 1 
autoantibody 1 
poor 1 8 9 
outcome 1 2 3 4 5 6 9 
COVID-19.Ana 1 
Rodriguez 1 
David 1 
Lee 1 
NYU 1 
Grossman 1 
School 1 5 6 
Medicine 1 5 6 
New 1 6 9 
York 1 
City 1 
level 1 2 3 5 6 8 9 
collect 1 2 3 4 5 9 
require 1 5 7 9 
hospitalization 1 2 3 4 5 
particularly 1 2 4 7 9 
interested 1 
annexin 1 
A2 1 
stabilize 1 
cell-membrane 1 
structure 1 
play 1 3 
part 1 4 9 
ensure 1 3 5 9 
integrity 1 9 
vessel 1 
Blocking 1 2 5 
injury 1 5 7 9 
hallmark 1 
COVID-19.The 1 
scientist 1 
anti-annexin 1 
average 1 4 
eventually 1 
die 1 2 3 8 9 
survive 1 3 
difference 1 2 3 4 5 8 9 
statistically 1 7 9 
significant 1 2 3 9 
M. 1 2 
Zuniga 1 
medRxiv 1 
//doi.org/fqdd 1 
necessary 1 9 
establish 1 
clear 1 2 4 5 
causal 1 
rare 1 
reviewed.8 1 
Quick 1 
treatment 1 2 3 4 5 7 9 
antibody-laden 1 
cut 1 
risk 1 2 3 4 5 6 7 8 9 
COVIDA 1 
clinical 1 2 3 4 5 7 9 
trial 1 2 3 4 5 
old 1 2 3 4 5 6 
adult 1 2 6 9 
early 1 2 3 4 5 8 9 
dose 1 3 4 5 
plasma 1 2 4 5 9 
recovered 1 9 
prevent 1 2 4 5 6 
progression 1 2 3 5 
disease.The 1 
contains 1 
mix 1 
need 1 2 3 4 6 9 
give 1 2 3 4 5 6 7 8 9 
disease 1 2 3 4 5 6 7 9 
course 1 2 3 4 5 7 
effective 1 2 4 6 7 
Fernando 1 
Polack 1 
Fundación 1 2 
INFANT 1 2 
Buenos 1 2 
Aires 1 2 
conduct 1 2 3 4 5 
rigorous 1 
assess 1 2 3 4 5 8 9 
hour 1 2 3 4 5 8 
onset 1 2 4 5 9 
Participants 1 9 
include 1 2 3 4 5 6 7 8 9 
age 1 2 3 4 5 7 9 
least 1 2 3 4 5 6 7 9 
pre-existing 1 7 
condition 1 2 3 4 5 6 9 
diabetes 1 2 9 
Libster 1 2 
N. 1 
Engl 1 
Med 1 
//doi.org/10.1056/NEJMoa2033700 1 
.Severe 1 
develop 1 2 5 6 9 
participant 1 9 
receive 1 2 3 4 5 6 9 
placebo 1 2 3 4 5 
group 1 2 3 4 5 6 8 9 
donor 1 2 
concentration 1 2 4 9 
associate 1 2 3 4 8 9 
great 1 2 3 4 6 8 9 
provide 1 2 3 4 5 6 7 8 9 
evidence 1 5 9 
responsible 1 4 7 
therapeutic 1 2 4 7 
effect.7 1 
Evidence 1 
grows 1 
coronavirus 1 2 3 4 5 7 9 
swift 1 
spreadTwo 1 
independent 1 2 4 
analysis 1 2 3 4 5 9 
overtake 1 
United 1 3 5 
Kingdom 1 
indeed 1 
transmissible 1 
form 1 2 4 5 9 
virus.Eric 1 
Volz 1 
Neil 1 
Ferguson 1 
Imperial 1 5 
College 1 9 
London 1 
genome 1 
label 1 
concern 1 3 9 
October 1 2 5 
December 1 3 4 
analyse 1 3 4 9 
roughly 1 
UK 1 
administer 1 2 3 4 5 7 
late 1 2 5 
E. 1 
//doi.org/ghrqv8 1 
.Estimating 1 
frequency 1 5 8 
time 1 2 3 4 5 6 8 9 
author 1 2 3 4 5 9 
conclude 1 
lockdown 1 7 
November 1 2 3 
curb 1 
case 1 2 3 6 7 8 9 
viral 1 2 3 4 5 7 9 
rise 1 
reviewed.A 1 
separate 1 4 8 
use 1 2 3 4 5 7 9 
genomic 1 
data 1 2 3 4 5 7 8 9 
spread 1 5 6 7 
last 1 2 3 5 
month 1 2 4 8 9 
Davies 1 
Hygiene 1 
Tropical 1 
estimate 1 2 3 4 5 9 
//doi.org/fp3v 1 
review.6 1 
less-sensitive 1 
outbreaksRapid 1 
trade 1 
away 1 
degree 1 3 
reliability 1 
speed 1 
prove 1 
valuable 1 7 
public-health 1 
tool 1 2 9 
community 1 6 8 
hit 1 
hard 1 8 
disease.In 1 
week 1 8 
Diane 1 
Havlir 1 
California 1 5 
San 1 
Francisco 1 
city 1 
G. 1 
Pilarowski 1 
Clin 1 
Inf 1 
Dis 1 
//doi.org/fpzv 1 
volunteer 1 
gold-standard 1 
PCR 1 5 7 
typically 1 
return 1 2 8 
day 1 2 3 4 5 8 9 
States 1 3 5 6 
rapid 1 2 4 7 
detect 1 2 3 
antigen 1 
BinaxNOW 1 
Abbott 1 
Laboratories 1 
Park 1 
Illinois.The 1 
positive 1 2 3 4 5 7 9 
rapid-test 1 
phone 1 
advise 1 
meant 1 
less 1 2 5 9 
likely 1 3 8 9 
wait 1 
Approximately 1 
confirm 1 3 4 5 7 9 
mean 1 2 3 4 5 7 8 9 
wrong.Study 1 
disclose 1 
non-financial 1 
support 1 2 3 4 5 8 9 
relate 1 2 4 9 
paper.4 1 
― 1 
vaccine 1 2 6 
work 1 2 6 9 
quickly 1 8 
ward 1 
COVID-19An 1 
RNA-based 1 
recently 1 4 5 8 
approve 1 2 3 9 
US 1 
regulator 1 
protection 1 2 3 5 6 
first 1 2 3 4 9 
accord 1 3 4 5 7 9 
large 1 2 3 4 5 7 9 
trial.On 1 
Food 1 2 5 
Drug 1 2 5 9 
Administration 1 2 4 5 
grant 1 2 
emergency-use 1 
authorization 1 2 
Moderna 1 6 
Cambridge 1 
Massachusetts 1 
Shortly 1 
thereafter 1 
Lindsey 1 
Baden 1 
Brigham 1 
Women 1 5 9 
Hospital 1 2 8 9 
Boston 1 3 
Hana 1 
El 1 
Sahly 1 
Baylor 1 5 
Houston 1 2 
Texas 1 
publish 1 2 4 5 9 
enrol 1 3 4 9 
Half 1 
dos 1 3 4 5 
half 1 
apart 1 9 
L. 1 2 
//doi.org/ghrg8m 1 
symptomatic 1 3 4 7 
preliminary 1 
hint 1 
defence 1 
asymptomatic 1 2 5 7 8 9 
write 1 2 3 4 5 7 
experience 1 4 6 8 
side 1 2 
headache 1 
second 1 9 
serious 1 2 3 4 7 
occur 1 2 3 4 5 8 9 
frequently 1 5 7 
vaccinated 1 
group.21 1 
How 1 
French 1 
evade 1 
detectionIn 1 
France 1 
end 1 2 4 5 6 8 
resident 1 2 3 6 7 
undetected 1 
person 1 2 3 4 5 
nationwide 1 7 
surveillance 1 
programme.France 1 
reopen 1 
May 1 9 
adopt 1 8 
strategy 1 2 6 7 
contact 1 3 7 9 
tracing 1 
isolation 1 6 8 9 
keep 1 7 
check 1 
Vittoria 1 
Colizza 1 
Pierre 1 
Louis 1 
Institute 1 3 4 5 7 
Epidemiology 1 
Public 1 
Health 1 4 5 7 9 
Paris 1 
model 1 3 4 5 9 
transmission 1 8 
mid-May 1 
June 1 2 4 5 9 
national 1 
testing 1 4 
campaign 1 2 
miss 1 9 
country 1 2 3 
decline 1 5 9 
Pullano 1 
//doi.org/fn9k 1 
low 1 2 3 4 5 7 9 
rate 1 2 3 5 6 8 9 
always 1 
equate 1 5 
detected 1 
many 1 2 5 8 
seek 1 4 
medical 1 2 4 5 6 9 
advice 1 
testing.Countries 1 
implement 1 2 8 
aggressive 1 
efficient 1 9 
suspected 1 7 
useful 1 4 5 7 
fight 1 
pandemic 1 2 3 5 6 7 8 9 
say.18 1 
Stay-at-home 1 
order 1 2 3 9 
limit 1 2 3 4 7 8 9 
value 1 5 9 
COVIDAn 1 
measure 1 4 5 9 
school 1 6 9 
university 1 
closure 1 
restrict 1 8 
gathering 1 
shut 1 
business 1 
stay-at-home 1 
action 1 
bring 1 
marginal 1 
benefit.Questions 1 
linger 1 
relative 1 2 3 4 
effectiveness 1 
pinpoint 1 
Jan 1 9 
Brauner 1 
Oxford 1 
either 1 2 5 
easing 1 
restriction 1 7 8 9 
Science 1 9 
//doi.org/ghp2p7 1 
common 1 8 9 
anti-transmission 1 
measures.By 1 
combine 1 4 
set 1 2 4 9 
closing 1 
“ 1 2 4 6 
” 1 2 4 6 
dampen 1 
close 1 6 7 8 
quick 1 
succession 1 
impossible 1 2 
disentangle 1 
closure.In 1 
restricted 1 
little 1 8 
found.16 1 
Self-sabotaging 1 
COVIDAntibodies 1 
usually 1 
occasionally 1 
system 1 2 3 4 7 
erroneously 1 
organ 1 2 7 9 
even 1 4 5 8 9 
explain 1 3 
reaction 1 4 5 
SARS-CoV-2.Akiko 1 
Iwasaki 1 
Aaron 1 
Ring 1 
Yale 1 
Haven 1 6 
Connecticut 1 
seriously 1 
ill 1 2 3 6 9 
Y. 1 
Wang 1 9 
//doi.org/fnkt 1 
hamper 1 
Others 1 
central 1 2 3 4 5 7 
nervous 1 
heart 1 9 
liver 1 9 
connective 1 7 
tissue.No 1 
single 1 4 5 8 
enough 1 8 
distinguish 1 
uninfected 1 
say 1 8 
diversity 1 
various 1 3 4 
state 1 2 6 
follow 1 2 3 5 6 9 
COVID-19.14 1 
drug 1 4 7 
duo 1 
combination 1 2 
baricitinib 1 
remdesivir 1 3 
shave 1 
recovery 1 2 9 
hospitalize 1 2 3 5 
National 1 3 5 6 9 
Institutes 1 
recommend 1 3 6 8 
question 1 3 9 
World 1 
Organization 1 
caution 1 
use.To 1 
therapy 1 2 3 4 5 9 
Andre 1 
Kalil 1 
Nebraska 1 
Medical 1 2 4 5 9 
Omaha 1 
anti-inflammatory 1 
moderate 1 3 5 
C. 1 
//doi.org/ghpbd2 1 
control 1 2 3 4 5 8 
monitor 1 2 3 4 9 
long 1 2 4 9 
take 1 2 6 7 8 9 
sustained 1 
care.Those 1 
median 1 2 3 4 5 9 
compare 1 2 3 4 5 7 8 9 
edge 1 
invasive 1 2 3 9 
ventilation 1 2 3 9 
fell 1 
alone 1 2 3 
drugs.11 1 
save 1 2 
life 1 2 8 9 
scarceFront-line 1 
health-care 1 8 
worker 1 6 
probably 1 
get 1 5 
next 1 4 8 
queue 1 
supply 1 
Models 1 
elderly 1 
people.Kate 1 
Bubar 1 
Daniel 1 2 
Larremore 1 
Colorado 1 
Boulder 1 
roll 1 
priority 1 3 6 8 
K. 1 
//doi.org/ghj6xw 1 
influence 1 
population 1 2 3 4 5 6 7 8 9 
delivery 1 
offer 1 8 
vaccine.The 1 
scenario 1 
jab 1 
possible 1 4 5 7 
prioritize 1 6 
young 1 
analysis.Targeting 1 
death 1 2 3 4 5 6 7 8 9 
hard-hit 1 
achieve 1 4 
history 1 4 9 
recent 1 4 5 6 
benefitPeople 1 
front-runner 1 
still 1 8 9 
potent 1 5 
jab.Biotech 1 
firm 1 
report 1 2 3 4 5 7 9 
gauge 1 
Alicia 1 
Widge 1 
Allergy 1 5 
Infectious 1 5 
Diseases 1 5 
Bethesda 1 
Maryland 1 6 
T. 1 
//doi.org/ghnhnv 1 
latch 1 
key 1 3 4 
peak 1 
slightly 1 5 
subsequent 1 4 5 9 
neutralize 1 4 5 
none 1 5 
vaccine-related 1 
effects.The 1 
durable 1 
write.7 1 
Just 1 
pinch 1 
protect 1 
COVIDLow 1 
sufficient 1 4 8 
monkey 1 
contribute 1 2 4 5 7 
immunity 1 4 
low.There 1 
easy 1 
way 1 3 5 9 
predict 1 5 9 
aspect 1 9 
infectious 1 5 6 9 
Dan 1 
Barouch 1 
Harvard 1 
understand 1 9 
element 1 8 
defend 1 
rhesus 1 
macaque 1 
Macaca 1 
multatta 1 
.The 1 2 3 4 
McMahan 1 
//doi.org/fmjk 1 
recipient 1 2 
animal 1 5 
boost 1 
activation 1 9 
antibody-dependent 1 
natural 1 4 5 
killer 1 
Higher 1 3 
confer 1 
doses.When 1 
CD8+ 1 
re-infection 1 9 
immunity.4 1 
Smell 1 
sniff 1 
countsA 1 
fast 1 
cheap 1 
smell 1 9 
stop 1 2 
outbreak 1 2 6 8 
models.Previous 1 
three-quarters 1 
lose 1 
sense 1 5 
statistic 1 
hold 1 6 
true 1 
feel 1 
distinctive 1 
prompt 1 
Roy 1 
Parker 1 
mass 1 
loss 1 8 9 
quash 1 
epidemic 1 
D. 1 
B. 1 
//doi.org/fmbb 1 
simulation 1 
assume 1 3 
detectable 1 2 
event 1 2 3 4 5 9 
aeroplane 1 
flight 1 
modelling 1 
showed.Study 1 
company 1 
Darwin 1 
Biosciences 1 
Derek 1 
Toomre 1 
founder 1 
smell-test 1 
u-Smell-it 1 
reviewed.3 1 
let 1 
antibodies 1 
slipScientists 1 
allow 1 3 4 8 9 
recognition 1 
several 1 2 4 5 6 9 
manufacture 1 
treatments.The 1 
designer 1 
monoclonal 1 2 3 4 5 
naturally 1 
map 1 
binding 1 5 
Eli 1 5 
Lilly 1 5 
Indianapolis 1 5 
Indiana 1 5 
cocktail 1 4 
Regeneron 1 4 
Tarrytown 1 
Starr 1 
//doi.org/fk6h 1 
affect 1 2 3 4 6 7 
segment 1 
receptor-binding 1 4 5 
enter 1 
others 1 2 9 
antibodies.Few 1 
circulate 1 
widely 1 2 
prevalent 1 7 
Europe 1 
Netherlands 1 
Denmark 1 
mink 1 
farm 1 
reviewed.2 1 
sensitive 1 
yield 1 
false 1 
negativesThe 1 
method 1 3 4 5 9 
diagnose 1 5 9 
polymerase 1 
chain 1 
genetic 1 7 
material 1 
nose 1 
throat 1 2 
swab 1 4 5 7 
survey 1 7 9 
negative 1 2 4 9 
test.Caitlin 1 
Dugdale 1 
General 1 
look 1 
think 1 
reason 1 4 5 8 9 
Open 1 
Forum 1 
Infect 1 
//doi.org/fkw4 1 
Nearly 1 5 
do 1 7 9 
weeks.Among 1 
initial 1 4 
infection.People 1 
retested 1 
especially 1 3 
area 1 3 4 
widespread 1 
say.1 1 
avoid 1 2 8 
beware 1 
near 1 8 
dearestA 1 
far-reaching 1 
China 1 3 8 9 
Hunan 1 
Province 1 
encounter 1 8 
member 1 2 4 6 8 
household.Kaiyuan 1 
Sun 1 
Hongjie 1 
Yu 1 
Fudan 1 
Shanghai 1 
//doi.org/fkwm 1 
live 1 8 9 
together 1 4 7 9 
pose 1 7 
extended 1 
family 1 2 4 8 9 
social 1 3 6 8 9 
public 1 3 6 
transport 1 2 
extra 1 
raise 1 9 
found.The 1 
actually 1 
increase 1 2 3 4 5 7 8 9 
household 1 
spend 1 8 
normal 1 2 4 8 9 
home 1 2 6 8 9 
period.20 1 
responses 1 
persist 1 5 9 
monthsThe 1 
memory 1 
lingers 1 
people.Sporadic 1 
account 1 8 
reinfection 1 
rapidly 1 3 5 
dwindle 1 
Shane 1 
Crotty 1 
La 1 2 
Jolla 1 
Immunology 1 
marker 1 5 
range 1 2 3 4 5 9 
//doi.org/ghkc5k 1 
tend 1 
defender 1 
B 1 9 
jump-start 1 
production 1 
re-encountered 1 
CD4+ 1 
peer-reviewed.19 1 
mutate 1 
race 1 3 
farmsThe 1 
adapt 1 4 
farmed 1 
SARS-CoV-2.Outbreaks 1 
breed 1 
Neovison 1 
vison 1 
Mustela 1 
lutreola 1 
April 1 7 
François 1 
Balloux 1 
van 1 
Dorp 1 
//doi.org/fjj6 1 
instance 1 5 
jump 1 
arise 1 
independently 1 4 
twice 1 
host.Some 1 
frequent 1 5 7 
appear 1 2 3 4 5 8 
encode 1 
coronaviruses 1 
back 1 
human 1 3 4 6 
reviewed.17 1 
Colds 1 
COVIDAlthough 1 
deadly 1 
mild-mannered 1 
cousin 1 
seasonal 1 
cold 1 
shield 1 
coronavirus.Scott 1 
Hensley 1 
Pennsylvania 1 
Philadelphia 1 
Anderson 1 
//doi.org/fh2n 1 
pre-pandemic 1 
OC43 1 
One-quarter 1 
common-cold 1 
coronavirus.Half 1 
catch 1 
Individuals 1 
become 1 2 3 4 5 6 
similar 1 3 4 5 9 
say.17 1 
infectiousRapid 1 
faster 1 
user-friendly 1 
standard 1 2 3 5 
diagnostic 1 9 
assay 1 2 4 5 9 
assessment 1 3 4 5 7 9 
tell 1 
accuracy 1 2 3 4 9 
infectious.Antigen-based 1 
surface 1 
particle 1 
Christian 1 
Drosten 1 
Charité 1 
Berlin 1 
performance 1 
commercially 1 
available 1 2 3 4 5 6 8 9 
apply 1 8 
dozen 1 
already 1 3 4 8 
V. 1 
Corman 1 
//doi.org/ghj3wt 1 
presence 1 4 5 7 
run 1 
equivalent 1 3 5 
copy 1 4 
millilitre 1 
Such 1 5 6 8 
observe 1 2 3 4 5 7 8 9 
reviewed.13 1 
swiftly 1 
bodyThe 1 
resurge 1 
man 1 9 
kill 1 
fast-paced 1 
evolution.Manuela 1 
Cernadas 1 
Jonathan 1 2 
Li 1 
45-year-old 1 
long-standing 1 
autoimmune 1 7 
disorder 1 9 
medication 1 
regimen 1 
powerful 1 
immunosuppressant 1 
Choi 1 
//doi.org/fhv8 1 
follow-up 1 2 3 7 9 
surge 1 
antiviral 1 3 4 5 9 
treatment.The 1 
subside 1 
diagnosis 1 2 9 
Genomic 1 
multiple 1 2 3 5 8 
Instead 1 8 
body.12 1 
mystery 1 
African 1 4 
nation 1 
tollOne 1 
mid-2020 1 
Kenya 1 3 
surprisingly 1 
figure 1 9 
view 1 
small 1 2 4 5 9 
Sophie 1 
Uyoga 1 
KEMRI-Wellcome 1 
Trust 1 
Programme 1 
Kifili 1 
search 1 9 
donate 1 2 
mid-June 1 
S. 1 4 
//doi.org/fhsx 1 
Based 1 
infection.The 1 
prevalence 1 5 7 
Spain 1 
July 1 2 
whereas 1 3 5 7 
sharp 1 
contrast 1 
Africa.11 1 
weaken 1 
powerA 1 
potential 1 2 3 4 5 9 
infection.Since 1 
start 1 8 
Robertson 1 
Glasgow 1 
Gyorgy 1 
Snell 1 
Vir 1 
Biotechnology 1 
N439K 1 
invade 1 
Thomson 1 
//doi.org/fhnp 1 
emerge 1 3 5 9 
countries.In 1 
laboratory 1 3 5 9 
experiment 1 
hinder 1 
block 1 2 
obstruct 1 
well 1 2 3 4 5 6 7 9 
reviewed.9 1 
Uninfected 1 
child 1 6 
coronavirusScientists 1 
never 1 
Children 1 
mild 1 2 3 5 9 
illness 1 2 3 5 6 9 
all.It 1 
unclear 1 5 9 
previous 1 2 4 8 9 
George 1 
Kassiotis 1 
Francis 1 
Crick 1 
W. 1 
Ng 1 
//doi.org/fg9k 1 
begin 1 
global 1 3 5 9 
march.The 1 
So 1 
lab 1 
dishes.6 1 
mimic 1 
antibodiesA 1 
candidate 1 2 
artificial 1 9 
variety 1 
trigger 1 5 
protective 1 8 
response.David 1 
Veesler 1 
King 1 
design 1 2 3 4 5 9 
microscopic 1 
ball-shaped 1 
Walls 1 
Cell 1 2 5 
//doi.org/fg6r 1 
fuse 1 
outside 1 8 9 
nanoparticles 1 
inject 1 
mouse 1 
nanoparticle 1 
virus-blocking 1 
comparable 1 
Mice 1 
ten 1 9 
rodent 1 
vaccinate 1 6 
rely.The 1 
strong 1 
special 1 4 
SARS-CoV-2.4 1 
Many 1 
RNA 1 2 5 
itSwabbing 1 
bank 1 
machine 1 
shop-door 1 
handle 1 
touch 1 
reveal 1 6 
present 1 2 4 5 8 9 
amounts.Amy 1 
Pickering 1 
Tufts 1 
Medford 1 
repeatedly 1 6 
place 1 2 6 8 
Somerville 1 
P. 1 
Harvey 1 
//doi.org/fgx9 1 
rubbish 1 
bin 1 
liquor 1 
store 1 2 
riddle 1 
low-level 1 
contamination 1 
contaminated 1 
say.The 1 
percentage 1 2 3 4 5 9 
postal 1 
district 1 
Sampling 1 
heavily 1 
warning 1 8 
often 1 3 7 8 
silentThe 1 
efficiently 1 4 
warn 1 
intensive 1 2 3 5 8 9 
monitoring 1 2 3 4 6 7 
households.Melissa 1 
Rolfes 1 
Centers 1 3 6 
Disease 1 2 3 6 
Control 1 3 6 
Prevention 1 3 6 
Atlanta 1 
Georgia 1 
recruit 1 4 
Grijalva 1 
Morb 1 
Mortal 1 
Wkly 1 
Rep. 1 
//doi.org/fgx3 1 
enrolment 1 
gather 1 4 
daily 1 2 
conservative 1 
exclude 1 2 3 4 9 
sign 1 2 3 5 7 8 
remain 1 2 8 9 
almost 1 4 9 
double 1 
Fewer 1 
ill.2 1 
rank 1 
infectionsA 1 
tally 1 
total 1 2 3 4 5 9 
infected.Megan 1 
O 1 2 
Driscoll 1 
//doi.org/fgts 1 
pattern 1 3 9 
consistent 1 3 4 5 9 
countries.The 1 
compile 1 2 
previously 1 5 7 8 9 
expose 1 
fatality 1 
proportion 1 2 3 7 9 
under-65 1 
beginning 1 
September 1 3 4 5 
Korea 1 
Peru 1 3 
.This 1 
say.30 1 
Coronavirus-fighting 1 
mostly 1 
COVID-19.Ania 1 
Wajnberg 1 
Icahn 1 
Mount 1 
Sinai 1 
//doi.org/fgfs 1 
More 1 4 9 
cells.The 1 
re-tested 1 
date 1 3 9 
stable 1 9 
modest 1 9 
re-infection.28 1 
fur-farm 1 
coronavirusThe 1 
fox-like 1 
raccoon 1 
dog 1 
Nyctereutes 1 
procyonoides 1 
themselves.Conrad 1 
Freuling 1 
Friedrich 1 
Loeffler 1 
Greifswald–Isle 1 
Riems 1 
Germany 1 9 
deliberately 1 
Emerg 1 
//doi.org/ffzf 1 
Six 1 
shed 1 
later 1 7 
put 1 8 
cage 1 
None 1 2 
visibly 1 
sick 1 
lethargic.These 1 
fur 1 
captivity 1 
acute 1 2 3 4 5 7 8 9 
syndrome 1 2 3 4 5 7 9 
canids.27 1 
Basketball 1 
star 1 
score 1 5 9 
insightsProfessional 1 
basketball 1 
player 1 
detail 1 5 9 
poorly 1 
understood 1 3 
phase 1 3 4 5 6 7 9 
cycle 1 5 8 
behaviour 1 
newly 1 9 
people.After 1 
four-month 1 
hiatus 1 
game 1 
resume 1 9 
restart 1 
athlete 1 
staff 1 6 8 9 
highly 1 5 7 
chance 1 8 
felt 1 
ill.Stephen 1 
Kissler 1 
T.H 1 
Chan 1 
season 1 
//doi.org/ffxk 1 
Study 1 4 
fall 1 
information 1 2 4 5 9 
decision 1 3 6 9 
reviewed.26 1 
maths-based 1 
streamlines 1 
testingIn 1 
pool 1 4 5 
batch 1 
large-scale 1 
theory 1 
predicted.Moran 1 
Yassour 1 
Hebrew 1 
Jerusalem 1 
Barak 1 
//doi.org/ffkx 1 
constituent 1 
Groups 1 
retested.Using 1 
one-quarter 1 
individually 1 
few 1 5 
expect 1 4 8 
care 1 2 3 4 5 6 8 9 
hospital 1 2 3 5 7 8 9 
likelihood 1 3 4 
reviewed.23 1 
Promising 1 
livesA 1 
mute 1 
deal 1 
blow 1 
once-popular 1 
hypothesis 1 3 4 
launch 1 
excessive 1 
grave 1 
overly 1 
vigorous 1 
bolster 1 
association 1 4 5 7 9 
IL-6 1 
COVID-19.John 1 
Stone 1 
try 1 
treat 1 2 3 5 7 
tocilizumab 1 3 
interfere 1 
H. 1 
//doi.org/ffjp 1 
randomized 1 2 3 
rule 1 4 
possibility 1 
statistical 1 2 4 5 9 
power 1 2 3 5 
uncover 1 
benefit.20 1 
Genomics 1 
care-home 1 
deathsAn 1 
explosive 1 
town 1 
spilt 1 
surround 1 
local 1 3 4 
homes.Public-health 1 
official 1 6 
easily 1 
cascade 1 
Crosse 1 
Wisconsin 1 
universities.Paraic 1 
Kenny 1 
Gundersen 1 
Foundation 1 2 9 
County 1 5 
student 1 
in-person 1 4 
Richmond 1 
//doi.org/fdt3 1 
overwhelming 1 
packed 1 
party 1 
indoors 1 
outdoors 1 
Eight 1 
reviewed.19 1 
courseViral 1 
pass 1 8 
peak.A 1 
doctor 1 
load 1 4 5 
indicator 1 
amount 1 
James 1 
Hay 1 
correlate 1 2 3 4 5 7 
J 1 
//doi.org/ghfm73 1 
.Early 1 
therefore 1 3 4 7 
Later 1 
load.As 1 
snapshot 1 
viral-load 1 5 
distribution 1 2 6 9 
random 1 9 
susceptible 1 
bias 1 
COVID-testing 1 
practice 1 3 8 
simply 1 5 8 
count 1 9 
reviewed.16 1 
Are 1 
dependsRapid 1 
minute 1 2 
market 1 
equally 1 2 5 
virus.Antigen-based 1 
inexpensive 1 2 
Marion 1 
Koopmans 1 
Erasmus 1 
Rotterdam 1 
slow 1 4 5 
Beek 1 
//doi.org/fdmg 1 
cases.All 1 
come 1 
pick 1 
reviewed.15 1 
shrug 1 
temperature 1 2 
changesThe 1 
arrival 1 
spring 1 
summer 1 
stage 1 2 4 9 
pandemic.Influenza 1 
viruses 1 
dry 1 2 
warmer 1 
humid 1 
environment 1 
winter 1 
mixed 1 3 4 5 
picture 1 
behaviour.To 1 
see 1 2 4 
Canelle 1 
Poirier 1 
Mauricio 1 
Santillana 1 
create 1 6 
incorporate 1 
mid-January 1 
mid-February 1 
Sci 1 
weather 1 
domestic 1 
travel 1 8 
instigate 1 
government.The 1 
variability 1 
continue 1 2 3 4 5 
tropical 1 
climate 1 
dry.14 1 
build 1 2 
coronavirus-fighting 1 
antibodyResearchers 1 
proteins 1 
cells.Neutralizing 1 
promising 1 5 
experimental 1 2 
treatment.A 1 
Pamela 1 
Bjorkman 1 
Technology 1 9 
Pasadena 1 
determine 1 2 3 5 9 
shape 1 
attach 1 
gain 1 4 5 
foothold 1 
O. 1 
Barnes 1 
//doi.org/fc8d 1 
divide 1 3 4 5 9 
cell-attachment 1 
recognize.Further 1 
foil 1 
others.13 1 
Common-cold 1 
coronavirusResearch 1 
archived 1 
bear 1 
hope 1 
COVID-19.Paul 1 
Bieniasz 1 
Theodora 1 
Hatziioannou 1 
Rockefeller 1 
blood-serum 1 
Poston 1 
//doi.org/fc4g 1 
cold.The 1 
dish 1 
hybrid 1 
engineer 1 
crucial 1 
invasion 1 
role 1 3 4 9 
fare 1 
bad 1 3 9 
Dense 1 
brace 1 
tear 1 
generally 1 3 
close-knit 1 
spreading 1 
crowded 1 6 
neighbourhood 1 
intermingle 1 
ultimately 1 8 
isolated 1 
areas.Moritz 1 
Kraemer 1 
size 1 2 5 8 9 
density 1 9 
Rader 1 
//doi.org/fcjk 1 
validate 1 5 
output 1 
know 1 5 8 
movement 1 7 
Chinese 1 9 
Wuhan 1 8 9 
densely 1 
province 1 
Italy.The 1 
predicts 1 
short 1 4 8 9 
intense 1 
uncrowded 1 
stick 1 
rather 1 
mingle 1 
freely 1 7 9 
however 1 3 6 9 
cope 1 
countryside.The 1 
worldwide 1 2 7 
Ulaanbaatar 1 
Mongolia 1 
short-term 1 
explosion 1 
settled 1 
urban 1 
centre 1 7 
Madrid 1 
protracted 1 
outbreaks.6 1 
Teenager 1 
holidayA 1 
13-year-old 1 
girl 1 
grandparent 1 
occupy 1 
holiday 1 
house 1 
adolescent 1 
seed 1 
cluster 1 
cases.According 1 
investigation 1 2 7 9 
Noah 1 
Schwartz 1 
join 1 
stay 1 9 
5-bedroom 1 
//doi.org/10.15585/mmwr.mm6940e2 1 
Family 1 8 
neither 1 
wear 1 
mask 1 
maintain 1 2 5 
distance 1 9 
teenage 1 
classify 1 4 7 9 
probable 1 
visit 1 2 3 4 5 8 9 
ill.5 1 
Massive 1 
contact-tracing 1 
effort 1 9 
India 1 
reveals 1 
strike 1 4 
trendsThe 1 
differ 1 2 9 
starkly 1 
resource-poor 1 
setting 1 5 6 8 
wealthy 1 
far 1 
India.Joseph 1 
Lewnard 1 
Berkeley 1 
Tamil 1 
Nadu 1 
Andhra 1 
Pradesh 1 
Laxminarayan 1 
//doi.org/10.1126/science.abd7672 1 
incidence 1 3 4 8 
steadily 1 
climb 1 
Mortality 1 3 
markedly 1 
perhaps 1 2 
younger.The 1 
socialise 1 
kid 1 
spread.2 1 
trait 1 
reinfectionWaning 1 
suggests.In 1 
March 1 7 
sixty 1 
spent 1 
milder 1 
cough 1 2 
shortness 1 
breath.Genomic 1 
Jason 1 
Goldman 1 
//doi.org/fbvj 1 
decrease 1 2 5 9 
measurement 1 4 
benchmark 1 
reviewed.1 1 
fast-spreading 1 
infectiousnessVariants 1 
hamster 1 
lack 1 2 4 6 
change.In 1 
February 1 
alter 1 3 
amino 1 
acid 1 
sequence 1 2 5 
amino-acid 1 
alteration 1 7 
D614G 1 
North 1 
America 1 
elsewhere 1 
alteration.To 1 
Pei-Yong 1 
Shi 1 
Branch 1 
Galveston 1 
Plante 1 
//doi.org/fbxz 1 
Ralph 1 
Baric 1 
Carolina-Chapel 1 
Hill 1 
Hou 1 
//doi.org/fbxx 1 
replicate 1 2 
airway 1 3 
tissue 1 7 
review 1 2 3 4 5 6 
yet.30 1 
promise 1 
peopleOlder 1 
prominent 1 
coronavirus.Evan 1 
Emory 1 
biotechnology 1 
base 1 4 5 
//doi.org/fbxj 1 
consist 1 3 9 
piece 1 
modified 1 2 3 4 9 
protein.Participants 1 
neutralizing 1 4 
disarm 1 
invading 1 
microbe 1 
control-group 1 
Any 1 
moderate.28 1 
Tests 1 
silent 1 
reinfections 1 
workersTwo 1 
reinfected 1 
instance.The 1 
employee 1 4 6 
25-year-old-man 1 
28-year-old 1 
woman 1 2 7 9 
Gupta 1 
//doi.org/d97d 1 
three-and-a-half 1 
May.Genomic 1 
Vinod 1 
Scaria 1 
Integrative 1 
Biology 1 
Delhi 1 
genetically 1 
anew 1 
virus.The 1 
underreported 1 
say.25 1 
breakdown 1 
dire 1 
illnessSome 1 
healthy 1 
dysfunction 1 2 9 
immune-signalling 1 
chemical 1 
type-1 1 
interferon 1 
infection.Type-I 1 
influenza 1 6 
Jean-Laurent 1 
Casanova 1 
DNA 1 
type-I 1 
Q. 1 
Zhang 1 
//doi.org/d95p 1 
render 1 
unable 1 8 9 
signalling 1 
chemicals.In 1 
severely 1 9 
Paul 1 
Bastard 1 
unknown 1 3 4 5 8 9 
//doi.org/d95q 1 
general 1 7 8 
Laboratory 1 9 
auto-antibodies 1 
knock 1 
activity.The 1 
disease.24 1 
Extreme 1 
quell 1 
epidemicAs 1 
two-thirds 1 
Manaus 1 
Amazonas 1 
virus.Ester 1 
Sabino 1 
São 1 
Paulo 1 
August 1 4 5 6 
F. 1 
Buss 1 
//doi.org/ghcm6h 1 
herd 1 
term 1 9 
spread.The 1 
source 1 3 
reviewed.22 1 
Good 1 3 4 
timing 1 
COVID-19People 1 
disorganized 1 
hard.The 1 
adaptive 1 
branch 1 
invader 1 
principle 1 4 5 
Alessandro 1 
Sette 1 
fatal 1 
Moderbacher 1 
//doi.org/ghbwh7 1 
fail 1 2 
entire 1 5 
arm 1 
ramp 1 
simultaneously 1 9 
uncoordinated 1 
weapon 1 
coronavirus.21 1 
Business-class 1 
passenger 1 
flightGenetic 1 
strongly 1 4 
married 1 
couple 1 
fly 1 
Hong 1 
Kong 1 
attendant 1 
trip.Researchers 1 
Leo 1 
Poon 1 
Deborah 1 
Watson-Jones 1 
early-March 1 
//doi.org/d9jn 1 
husband 1 
wife 1 
travelling 1 
crew 1 
cabin 1 
assignment 1 2 3 4 
Canada 1 
soon 1 2 
arrive 1 
shortly 1 
thereafter.The 1 
identical 1 4 
American 1 3 4 9 
transmit 1 
in-flight 1 
evidence.18 1 
Musicians 1 
monk 1 
superspreading 1 
KongAn 1 
households.In 1 
examination 1 9 
Peng 1 
Wu 1 
Adam 1 5 
//doi.org/d9c4 1 
perform 1 3 4 5 
bar 1 
big 1 
temple 1 
infected.Nearly 1 
anyone 1 8 
downstream 1 
wedding 1 
restaurant 1 
spread.17 1 
Immunity 1 
short-livedNatural 1 
decades.Previous 1 
matter 1 
Lia 1 
der 1 
Hoek 1 
Amsterdam 1 
mid-1980s 1 
Edridge 1 
//doi.org/ghbm79 1 
Infections 1 
months.15 1 
groundbreaking 1 
guide 1 6 
COVID-19A 1 
attacking 1 
inform 1 4 5 9 
development 1 2 4 9 
fend 1 
Antibodies 1 2 5 
inactivate 1 
attractive 1 
accumulate 1 9 
forces.James 1 
Crowe 1 
Vanderbilt 1 
Nashville 1 
Tennessee 1 
detailed 1 9 
spike-protein 1 
//doi.org/d8zm 1 
antibodies.In 1 
reviewed.14 1 
Kids 1 
childcare 1 
familiesTwelve 1 
twelve 1 
Utah 1 
presumptive 1 
child.Cuc 1 
Tran 1 
investigate 1 3 4 7 9 
Salt 1 
Lake 1 5 
Rept 1 
//www.cdc.gov/mmwr/volumes/69/wr/mm6937e3.htm 1 
s_cid=mm6937e3_w 1 
known 1 6 
symptoms.All 1 
year 1 2 3 4 5 7 9 
mother 1 
sibling 1 
eight-month-old 1 
baby 1 
parent 1 
Not 1 
say.11 1 
illSome 1 
incident 1 
virus.Luca 1 
Ferretti 1 
someone 1 
else 1 
//doi.org/d8ms 1 
.They 1 
around 1 
day.The 1 
importance 1 5 
physical 1 8 9 
distancing 1 6 
pre-symptomatic 1 
self-isolation 1 
fever 1 3 9 
fatigue 1 2 9 
mild.10 1 
Surprise 1 
tantalize 1 
unveiledResearchers 1 
discover 1 
mysterious.Until 1 
instruction 1 
active 1 2 3 4 
inside 1 
uncertain 1 
Noam 1 
Stern-Ginossar 1 
Weizmann 1 
Rehovot 1 
Israel 1 
bound 1 
protein-making 1 
ribosome 1 
Finkel 1 
//doi.org/d8pb 1 
scan 1 
entirely 1 4 
shorten 1 
extend 1 
proteins.Some 1 
newfound 1 
unknown.9 1 
immune-cell 1 
COVID-19Immune 1 
neutrophil 1 
prim 1 
mildly 1 2 
machine-learning 1 
reproduce 1 
aid 1 
identification 1 
critically 1 3 9 
ill.Neutrophils 1 
comprise 1 
damage 1 7 9 
Hyung 1 
Chun 1 
learn 1 
Meizlish 1 
//doi.org/d8hm 1 
.Several 1 
health 1 2 3 6 8 9 
record 1 2 9 
increased 1 7 
mortality 1 2 3 5 9 
ravage 1 
unique 1 
profileMost 1 
failure 1 2 3 5 9 
tease 1 
devastating 1 
multisystem 1 
MIS-C.Doctors 1 
hundred 1 
MIS-C 1 
share 1 2 4 5 7 
similarity 1 
childhood 1 
Kawasaki 1 
biological 1 7 
profile 1 3 4 5 
Petter 1 
Brodin 1 
Karolinska 1 
Stockholm 1 
Consiglio 1 
//doi.org/d8fh 1 
IL-17A 1 
implicate 1 2 
deficit 1 
origin 1 
say.4 1 
Powerful 1 
steroid 1 7 
deathsPeople 1 
corticosteroid 1 9 
patient 1 2 3 4 5 7 8 9 
continents.Earlier 1 
dexamethasone 1 3 
ventilator 1 3 
Sterne 1 
Bristol 1 
meta-analysis 1 
REACT 1 
Working 1 
Group 1 2 5 9 
Am 1 
Assoc 1 
//doi.org/d7z8 1 
status 1 2 3 4 
randomly 1 2 3 4 5 
assign 1 2 3 4 5 
COVID-19.3 1 
genomics 1 
humansAn 1 
Dutch 1 
documented 1 
animal-to-human 1 
SARS-CoV-2.After 1 
Centre 1 
sequencing 1 
track 1 
Munnink 1 
//doi.org/d7xn 1 
farmworkers 1 
them.Genetic 1 
introduce 1 
unchecked 1 
reservoir 1 
dwindlingA 1 
sweeping 1 
Iceland 1 
endure 1 8 
counter 1 
disappear.After 1 
invades 1 
intruder 1 
Scientists 1 
generate 1 
persist.Kari 1 
Stefansson 1 
deCODE 1 
Genetics–Amgen 1 
Reykjavik 1 
Gudbjartsson 1 
//doi.org/gg9hbt 1 
Roughly 1 
plateaued 1 
duration 1 2 7 8 9 
study.The 1 
leave 1 2 8 
vulnerable 1 6 7 
wave 1 
warn.1 1 
Even 1 8 
octogenarians 1 
rip 1 
England 1 3 
80.During 1 
residential 1 
nursing 1 6 9 
Shamez 1 
Ladhani 1 
//doi.org/d7p2 1 
particular 1 3 9 
cellsThe 1 
guard 1 
peer-reviewed.28 1 
sleep-away 1 
camp 1 
outbreaksRigorous 1 
infection-control 1 
overnight 1 8 
Maine 1 
mid-August.Laura 1 
Blaisdell 1 
Portland 1 
ask 1 9 
attendee 1 
camper 1 
//www.cdc.gov/mmwr/volumes/69/wr/mm6935e1.htm 1 
s_cid=mm6935e1_w 1 
cohort 1 5 9 
quarantine 1 
cohort.Of 1 
attendees.27 1 
primary-school 1 
pupil 1 
spotChildren 1 
aged 1 
Kelly 1 
Duke 1 
Durham 1 
Carolina 1 2 
Hurst 1 
//doi.org/d7cb 1 
study.Only 1 
showed 1 
participants.Nearly 1 
one-third 1 
imply 1 
child.Screening 1 
day-care 1 
age-related 1 
Sex 1 
drive 1 2 4 5 
men 1 3 7 9 
riskVariations 1 
women.Akiko 1 
All 1 5 
Takahashi 1 
//doi.org/d7gb 1 
notice 1 
male 1 4 7 
typical 1 
female 1 7 
sex 1 9 
gender 1 9 
binary 1 
fixed 1 4 
inflammation-causing 1 
cytokine 1 
chemokines 1 
severity 1 3 5 9 
weak 1 
T-cell 1 
cytokines.The 1 
propose 1 8 
COVID-19.25 1 
Reinfection 1 
evidenceA 1 
analysis.People 1 
prevents 1 
durability 1 
signal 1 3 
wane 1 
prolong 1 
shedding 1 
materialKwok-Yung 1 
Yuen 1 
33-year-old 1 
K.-W. 1 
//doi.org/d7ds 1 
Genetic 1 
distinct 1 9 
bout.The 1 
fresh 1 
antibodies.21 1 
Vaccines 1 
infectionStudies 1 
nasal 1 9 
vaccination 1 6 
injected 1 
vaccine.David 1 
Curiel 1 
Michael 1 
Diamond 1 
St 1 
Missouri 1 
Hassan 1 
//doi.org/d63k 1 
bioengineered 1 
protein.After 1 
insert 1 
exposure 1 3 
measurable 1 
say.Ling 1 
Chen 1 5 
First 1 
Affiliated 1 
Guangzhou 1 
Feng 1 
Commun 1 
mulatta 1 
themselves.20 1 
illnessA 1 
East 1 
Asia 1 
unmutated 1 
virus.In 1 
Singapore 1 
chunk 1 
span 1 
ORF7b 1 
ORF8 1 
deletion 1 
Lisa 1 
Network 1 3 
Young 1 
Lancet 1 
//doi.org/d6x7 1 
.None 1 
supplemental 1 4 9 
oxygen 1 2 3 9 
Viruses 1 
possibly 1 
owe 1 5 9 
measures.The 1 
SARS 1 9 
acquire 1 
adaption 1 
say.Correction 1 
article 1 2 3 4 5 
DNA.19 1 
unprecedented 1 
chart 1 
proteinFor 1 
intact 1 
particles.Spike 1 
decorate 1 
lock 1 4 5 
ACE2 1 4 
entry 1 4 5 9 
glean 1 
express 1 9 
purify 1 
John 1 
Briggs 1 
Council 1 4 5 9 
Molecular 1 
electron 1 
microscopy 1 
Z. 1 
Ke 1 
//doi.org/d6sf 1 
.These 1 
closely 1 
resemble 1 
one 1 2 4 8 
confirmation 1 
open 1 2 3 4 5 
Studying 1 
spike-binding 1 
Sailors 1 
furnish 1 
re-infectionA 1 
massive 1 
fishing 1 
boat 1 
spar 1 
direct 1 3 7 9 
reinfected.After 1 
compound 1 
reinfection.Alexander 1 
Greninger 1 
Addetia 1 
//doi.org/d6qm 1 
ship 1 
departure 1 
SARS-CoV2 1 
shore.Post-voyage 1 
122-person 1 
embark 1 
SARS-CoV-2.But 1 
reviewed.7 1 
low-cost 1 
spitA 1 
painless 1 
spit 1 
testing.Chantal 1 
Vogels 1 
simple 1 2 
saliva 1 
SalivaDirect 1 
address 1 3 8 
demand 1 2 
extensive 1 
lockdowns 1 
lift 1 
//doi.org/d5s3 1 
.Compared 1 
trained 1 9 
professional 1 
scarce 1 
extract 1 
validation 1 9 
samples.The 1 
cost-per-spit 1 
request 1 5 
authorize 1 3 
emergency 1 2 4 5 
use.6 1 
protectionSome 1 
pandemic.Previous 1 
nevertheless 1 
Daniela 1 
Weiskopf 1 
Mateus 1 
//doi.org/d5v5 1 
activate 1 
weight 1 3 5 
exist 1 
conclusion.5 1 
Antibody 1 
blend 1 
symptomsA 1 
mixture 1 
COVID-19.Neutralizing 1 
Christos 1 
Kyratsous 1 
Pharmaceuticals 1 4 
infected.The 1 
Baum 1 
//doi.org/d5r9 1 
.Unlike 1 
Syrian 1 
golden 1 
Mesocricetus 1 
auratus 1 
acutely 1 
Summer-camp 1 
childrenDespite 1 
attend 1 4 8 9 
Georgia.Christine 1 
Szablewski 1 
Department 1 4 5 
//doi.org/d5ms 1 
sleep 1 9 
Campers 1 
masks.The 1 
teenager 1 
Factors 1 
describe 1 2 4 5 7 9 
singing 1 
cheer 1 
.30 1 
Vaccine 1 5 
protects 1 4 
infectionAn 1 
completely 1 3 6 9 
jab.Hanneke 1 
Schuitemaker 1 
Janssen 1 
Leiden 1 
Beth 1 
Deaconess 1 
Mercado 1 
//doi.org/d5d4 1 
weakened 1 
cod 1 
six.Across 1 
not.29 1 
unexposed 1 
peopleImmune 1 
prepared 1 
virus.At 1 
focus 1 2 3 4 5 7 8 
route 1 
Andreas 1 
Thiel 1 
react 1 
Braun 1 2 
//doi.org/d5bv 1 
speculate 1 
reactive 1 
past 1 
related 1 
SARS-CoV-2.28 1 
Mutations 1 
elude 1 
antibodiesMutations 1 
thwart 1 
molecules.The 1 
immune-system 1 
Researchers 1 
elicit 1 
vaccines.Theodora 1 
vesicular 1 
stomatitis 1 
livestock 1 
Weisblum 1 
//doi.org/d439 1 
engineered 1 
antibodies.The 1 
world 1 
Treatment 1 
cocktails 1 
evolve 1 7 
resistance 1 5 
reviewed.27 1 
virus-control 1 
symptomsIn 1 
metric 1 
serial 1 
interval 1 2 3 4 5 
shrink 1 
drastically 1 
underscore 1 3 9 
success 1 
efforts.The 1 
Benjamin 1 
Cowling 1 
plummet 1 
5-week 1 
period 1 2 3 4 7 9 
Ali 1 
//doi.org/gg5mpc 1 
otherwise 1 4 9 
fewer 1 
shrank.The 1 
real 1 
transmissibility 1 
virus.24 1 
Dogs 1 
cat 1 
mirror 1 
peopleCats 1 
northern 1 7 
Italy 1 7 
pet 1 
far.Nicola 1 
Decaro 1 
Bari 1 
rectal 1 
I. 1 
Patterson 1 
//doi.org/d4r7 1 
COVID-19.None 1 
circulating 1 
infection.Infection 1 
unusual 1 
reviewed.24 1 
Virus 1 
Israeli 1 
suspendedMore 1 
secondary 1 2 3 4 5 9 
remove 1 
heat-wave.Roughly 1 
fully 1 3 4 5 
Stein-Zamir 1 
Ministry 1 
Euro 1 
Surveill 1 
//doi.org/d4sw 1 
outbreak.The 1 
heat-wave 1 
heavy 1 
air-conditioning 1 
suspension 1 
requirement 1 4 
face 1 6 
Crowding 1 
classroom 1 
space 1 5 8 
allotment 1 6 
square 1 2 5 
metre 1 
student.22 1 
Severely 1 
diverse 1 
trove 1 
antibodiesScientists 1 
doses.The 1 5 
hostile 1 
Ho 1 
Columbia 1 
Vagelos 1 
Physicians 1 
Surgeons 1 
Liu 1 9 
//doi.org/d4md 1 
.Nineteen 1 
fasten 1 
site 1 2 3 4 8 
difficult 1 9 
mutation.21 1 
Viral 1 2 4 5 
treatmentThe 1 
clinician 1 
decide 1 2 6 
best 1 9 
Switzerland.Onya 1 
Opota 1 
Lausanne 1 
volume 1 9 
Jacot 1 
//doi.org/d4b8 1 
Early 1 2 
gradually 1 
progress 1 9 
characterize 1 4 
thus 1 3 4 
serve 1 
cue 1 
drugs.But 1 
correlation 1 
good 1 2 4 5 6 8 9 
predictor 1 4 5 
Antiviral 1 
peter 1 
infectionKey 1 
comprehensive 1 
yet.Neutralizing 1 
weeks.Katie 1 
Doores 1 
Seow 1 
//doi.org/d3s2 1 
preprint 1 
disease.However 1 
undetectable 1 
promote 1 
antibodies.15 1 
Positive 1 
hop 1 
top 1 
candidateA 1 
safety 1 2 3 4 5 
participants.The 1 
co-developed 1 
response.Lisa 1 
Jackson 1 
Kaiser 1 
Permanente 1 
injection 1 
//doi.org/d3tt 1 
complication 1 4 9 
fever.After 1 
capable 1 
30,000-participant 1 
III 1 
July.15 1 
Severe 1 2 4 
telltale 1 
profileScientists 1 
signature 1 
disease.Benjamin 1 
Terrier 1 
Hadjadj 1 
//doi.org/gg4vjx 1 
Compared 1 7 9 
intensive-care 1 
units.The 1 
Treatments 1 
say.13 1 
interior 1 
tag 1 
along 1 
move 1 9 
coastal 1 
import 1 
models.Alessandro 1 
Vespignani 1 
Northeastern 1 
traffic 1 
commute 1 
Davis 1 
//doi.org/d3mf 1 
international 1 
introduction 1 
non-coastal 1 
traveller 1 
visitor 1 8 
largely 1 9 
reviewed.10 1 
nightclubsMobile 1 
credit 1 
card 1 
fast-moving 1 
popular 1 
nightclub 1 
Seoul.Soon 1 
Korean 1 
note 1 3 5 
Seoul 1 
Itaewon 1 
club 1 
Jin 1 9 
Yong 1 
Boramae 1 
mobile 1 
payment 1 
Kang 1 
//doi.org/gg4fhj 1 
encourage 1 
undergo 1 2 4 5 7 9 
SARS-CoV-2.By 1 
step 1 
club-goers.9 1 
soar 1 
weeklyTo 1 
safely 1 
campus 1 
days.David 1 
Paltiel 1 
80-day 1 
semester 1 
//doi.org/d3cc 1 
.In 1 
cost 1 2 3 
However 1 2 3 4 5 7 8 9 
weekly 1 3 
growth 1 
infections.If 1 
manageable 1 
stress 1 9 
preventive 1 
essential 1 6 9 
wildly 1 
disparate 1 
ratesEurope 1 
symptoms.Between 1 
Marina 1 
Pollán 1 
Carlos 1 2 
select 1 2 4 9 
//doi.org/gg332t 1 
geographical 1 7 
variation 1 
provinces.Nationwide 1 
basis 1 2 4 6 
symptoms.7 1 
Autopsies 1 
autopsy-based 1 
mismatch 1 
hotspot 1 
death.Numerous 1 
Christopher 1 
Lucas 1 
Dorward 1 
Edinburgh 1 
autopsy 1 
//doi.org/d27t 1 
anatomical 1 
inflame 1 
Test 1 
sensitivity 1 
outbreaksCommunities 1 
spiral 1 
insensitive 1 
test.Tests 1 
rely 1 
technique 1 
quantitative 1 4 5 
qPCR 1 
mere 1 
trace 1 
expensive 1 
Mina 1 
//doi.org/d2gt 1 
pair 1 
finely 1 
Achilles 1 
heelScientists 1 
feat 1 
cells.Before 1 
fastens 1 
sit 1 3 
//doi.org/dz8r 1 
current 1 2 4 9 
pandemic.The 1 
impair 1 
knowledge 1 9 
striking 1 
classic 1 2 
symptomsLess 1 
Italy.More 1 
Lombardy 1 7 
epicentre 1 
Piero 1 
Poletti 1 
Bruno 1 
Kessler 1 
Trento 1 
Marcello 1 
Tirani 1 
Protection 1 6 
Agency 1 
Pavia 1 
person.Roughly 1 
//arxiv.org/abs/2006.08471 1 
developed 1 
odds 1 9 
preparation 1 
CRISPR 1 
invasionA 1 
trawl 1 
CRISPR–Cas9 1 
genome-editing 1 
hosts.The 1 
discovery 1 5 
Doench 1 
Broad 1 
MIT 1 
Craig 1 
Wilen 1 
cultured 1 
host-cell 1 
Wei 1 
//doi.org/dzz3 1 
code 1 
assist 1 
TGF-β 1 
pathway 1 
Chemicals 1 
inhibit 1 
coronavirus-induced 1 
Youth 1 
contactsPeople 1 
elder 1 
member.Yang 1 
Yang 1 
Florida 1 
Gainesville 1 
Zhi-Cong 1 
Jing 1 
//doi.org/dznw 1 
institute 1 
above.The 1 
facility 1 6 8 
families.17 1 
problem 1 8 9 
extent 1 9 
underlying 1 6 9 
disease.Andrew 1 
Clark 1 
cardiovascular 1 2 9 
predispose 1 
Glob 1 
//doi.org/dzk9 1 
Analysing 1 
elevate 1 
infected.These 1 
high-risk 1 3 5 6 
say.16 1 
Swiss 1 2 
infectionChildren 1 
Geneva 1 
Switzerland.Silvia 1 
Stringhini 1 
Hospitals 1 
//doi.org/dzh5 1 
tested 1 
positive.The 1 
stem 1 
response.15 1 
Bars 1 
karaoke 1 
gym 1 
superspread 1 
Clusters 1 
breathe 1 2 3 
pack 1 
session 1 
Japan.Hitoshi 1 
Oshitani 1 
Tohoku 1 
Sendai 1 
Japan 1 
venue 1 
Furuse 1 
//doi.org/ggz2hg 1 
nurse 1 
musical 1 
workplaces.One 1 
concert 1 
example 1 2 9 
performer 1 
audience 1 
staff.The 1 8 
virus.12 1 
Modified 1 3 
quest 1 
drugsTwo 1 
harmless 1 
impervious 1 
Transgenic 1 
scarce.To 1 
St. 1 5 
Jincun 1 
Zhao 1 
adenovirus 1 
workhorse 1 
deliver 1 
pneumonia.Diamond 1 
successfully 1 4 
//doi.org/dzbk 1 
//doi.org/dzbm 1 
headline 1 
Asia.COVID-19 1 
Oliver 1 
Pybus 1 
Andrew 1 
Rambaut 1 
Virological 1 
//go.nature.com/37ieyvw 1 
border 1 
underestimate.Travellers 1 
People 1 
reviewed.11 1 
conscript 1 
cellsResearchers 1 
us 1 
drugs.The 1 
Spike 1 2 
neuropilin-1 1 
NRP1 1 
invasion.Peter 1 
Cullen 1 
Yohei 1 
Yamauchi 1 
fragment 1 
Cantuti-Castelvetri 1 
//doi.org/dx5c 1 
Mikael 1 
Simons 1 
Technical 1 
Munich 1 
Daly 1 
//doi.org/dx5d 1 
laboratory.The 1 
virus-sized 1 
interaction 1 7 
combat 1 6 
infection.Neither 1 
fine 1 
unknowingly 1 
Vietnam 1 
others.Early 1 
admit 1 5 7 8 9 
negative.Of 1 
mid-March 1 
Le 1 
Van 1 
Tan 1 
Clinical 1 3 4 5 7 9 
Unit 1 
Chi 1 
Minh 1 
Chau 1 
//doi.org/ggzfz9 1 
.Nasal 1 
point 1 2 3 4 5 
say.8 1 
June— 1 
Lockdowns 1 
pandemicLockdowns 1 
resounding 1 
effectiveness.Samir 1 
Bhatt 1 
COVID-19-related 1 7 
European 1 
Flaxman 1 
//doi.org/dxxs 1 
policy 1 6 7 8 
aim 1 2 9 
May.In 1 
halt 1 
face-to-face 1 7 9 
.Solomon 1 
Hsiang 1 
//doi.org/dxxt 1 
avert 1 2 
infections.This 1 
spread.5 1 
Surfaces 1 
spreadContaminated 1 
minor 1 
households.Ricarda 1 
Schmithausen 1 
Bonn 1 
Döhla 1 
//doi.org/dxqn 1 
touched 1 
object 1 
door 1 
knob 1 
bathroom 1 
drain 1 
toilet 1 
samples.All 1 
aerosol 1 
interpret 1 4 
cautiously.The 1 
exhale 1 
coughed 1 
droplet 1 
main 1 9 
wastewater 1 
add.The 1 
reviewed.4 1 
Blood 1 
riskResearchers 1 
COVID-19.Tom 1 
Karlsen 1 
Oslo 1 
Ellinghaus 1 
//doi.org/dxk7 1 
disease.One 1 
lie 1 
swathe 1 
A+ 1 
flag 1 
chromosome 1 
interact 1 8 
molecular 1 
hail 1 
infectionA 1 
hydroxychloroquine 1 9 
COVID-19.Some 1 
leader 1 
embrace 1 6 
agent 1 2 3 4 5 
Boulware 1 
Minnesota 1 
Minneapolis 1 
//doi.org/dxkv 1 
person.About 1 
placebo.The 1 2 
caveat 1 
Therefore 1 2 4 5 
unaccounted 1 
for.2 1 
Could 1 
downplay 1 
underestimate 1 7 
SARS-CoV-2.In 1 
Isabel 1 
Rodríguez-Barraquer 1 
OSF 1 
Preprints 1 
//doi.org/dxc2 1 
fraction 1 2 5 
symptoms.The 1 
guarantee 1 
infectiousnessPeople 1 
cells.Jared 1 
Bullard 1 
Manitoba 1 
Winnipeg 1 
//doi.org/dw8z 1 
RNA-positive 1 
necessarily 1 8 
infectious.Hospital 1 
strictly 1 
says.29 1 
infectionThe 1 
starting 1 
infections.Richard 1 
Boucher 1 
Chapel 1 
ease 1 
tract 1 5 
gradient 1 
infectivity 1 4 
upper 1 2 3 5 
cavity 1 
deep 1 9 
//doi.org/dw2j 1 
neatly 1 
sneak 1 
preventative 1 
cleansing.28 1 
lost 1 
opportunity 1 8 9 
StatesGenomic 1 
contradict 1 
high-profile 1 
States.In 1 
publicize 1 
silently 1 
designate 1 4 
WA1 1 
transmission.But 1 
Worobey 1 
Arizona 1 
Tucson 1 
wider 1 
//doi.org/dwx3 1 
reviewed.The 1 
actual 1 3 
say.27 1 
Superspread 1 
portion 1 4 
infectionsAn 1 
extremely 1 
analysis.Adi 1 
Stern 1 
Tel 1 
Aviv 1 
Miller 1 
//doi.org/dwvb 1 
illustrate 1 
superspreaders 1 
transmission.The 1 
traveler 1 
disproportionate 1 3 
explanation 1 
ban 1 
arrivals.26 1 
Exposed 1 
adultsChildren 1 
systematic 1 3 
journal 1 
preprints 1 
reports.Russell 1 
Viner 1 
screen 1 2 4 
meet 1 2 3 5 9 
criterion 1 2 3 4 5 7 9 
inclusion 1 3 4 5 
//doi.org/dwp6 1 
.Studies 1 
conclude.The 1 
reviewed.25 1 
Trump 1 6 
favour 1 
benefit 1 2 3 4 8 9 
doesWorld 1 
President 1 
Donald 1 
tout 1 
antimalarial 1 5 
abnormal 1 9 
rhythms.Mandeep 1 
Mehra 1 
Heart 1 
Vascular 1 
draw 1 
continent 1 
//doi.org/ggwzsb 1 
chloroquine 1 9 
antibiotic.Compared 1 
disordered 1 
heartbeat 1 
arrhythmia 1 
drugs.A 1 
Beigel 1 
Rockville 1 
double-blind 1 2 3 4 5 
//doi.org/dwkd 1 
.Editors 1 
retraction 1 
//www.thelancet.com/lancet/article/s0140673620313246 1 
controversial 1 
paper 1 2 
hydroxychloroquine.22 1 
coronavirusMonkeys 1 
virus.Dan 1 
explore 1 5 9 
compose 1 3 
//doi.org/dwfb 1 
system.The 1 
multiplication 1 
unvaccinated 1 
check.21 1 
Potent 1 
inspire 1 
vaccineA 1 
disease.Davide 1 
Robbiani 1 
//doi.org/ggwfcm 1 
reviewed.People 1 
universally 1 
effective.21 1 
Monkeys 1 
resist 1 
virusMonkeys 1 
unclear.Public-health 1 
issue 1 3 6 7 9 
appetite 1 
Chandrashekar 1 
//doi.org/dwck 1 
.Roughly 1 
following 1 2 3 4 7 9 
virus.20 1 
organs 1 
brainAutopsies 1 
kidney 1 9 
brain 1 
organs.COVID-19 1 
principally 1 
consider 1 3 4 9 
non-respiratory 1 
stroke 1 9 
Tobias 1 
Huber 1 
Hamburg-Eppendorf 1 
abundant 1 
Puelles 1 
//doi.org/dv56 1 
scrutinize 1 
database 1 4 5 
Additional 1 4 
examined 1 
compartment 1 
illness.19 1 
relativeAn 1 
distant 1 8 
dub 1 
S309 1 
Davide 1 
Corti 1 
Bellinzona 1 
Switzerland 1 
Pinto 1 
//doi.org/dv4x 1 
structural 1 3 
attachment 1 
coronavirus-targeted 1 
alone.18 1 
ownersThe 1 
owner 1 
people.The 1 
Sit 1 
//doi.org/dvt4 1 
Only 1 5 9 
Pomeranian 1 
German 1 
shepherd 1 
noticeably 1 
sick.The 1 
people.15 1 
damageAn 1 
animals.Vincent 1 
Munster 1 
Hamilton 1 
Montana 1 
Sarah 1 
Gilbert 1 
Doremalen 1 
//doi.org/dvvd 1 
Vaccinated 1 
multiply 1 
way.15 1 
Lifting 1 
spell 1 
FranceMore 1 
stood 1 
immunity.Simon 1 
Cauchemez 1 
Pasteur 1 
Salje 1 
//doi.org/dvt3 1 
project 1 
relax 1 
infected.Some 1 
write.14 1 
choir 1 
infects 1 
dozensA 1 
State 1 
died.Lea 1 
Hamner 1 
Skagit 1 
Vernon 1 
numerous 1 6 7 
COVID-like 1 
evening 1 
2.5-hour 1 
attendance 1 
confirmed 1 4 9 
additional 1 2 3 4 5 
infections.Choir 1 
close-packed 1 
row 1 
sang 1 
emphasize 1 3 
crowd 1 
bay 1 
say.14 1 
hospitalChildren 1 
Europe.Silvia 1 
Garazzino 1 
Turin 1 
clinic 1 7 9 
Eurosurveillance 1 
//doi.org/dvk8 1 
reviewed.Nearly 1 
infant 1 
overall 1 3 4 5 7 8 
.Two-thirds 1 
did.13 1 
commutersNew 1 
commuter 1 
months.To 1 
Stephen 1 
birth 1 
//bit.ly/2Aq7dpb 1 
Facebook 1 
trip 1 
residents.Many 1 
say.12 1 
coronavirusPeople 1 
immune.Niloufar 1 
Kavian 1 
Valkenburg 1 
want 1 
Hachim 1 
//doi.org/ggtrxh 1 
controls.Much 1 
determinant 1 3 
SARS-CoV-2.11 1 
High 1 
minority 1 3 
ethnic 1 3 
troubling 1 
mysteryPeople 1 
white 1 9 
socioeconomic 1 3 
factor 1 3 4 5 7 8 9 
risk.In 1 
kind 1 
Ben 1 
Goldacre 1 
Williamson 1 
//doi.org/dt9z 1 
coronavirus.But 1 
belong 1 
heighten 1 
disadvantage 1 
income 1 
urgent 1 4 
disease.8 1 
recoveredNearly 1 
everyone 1 
disease.Ania 1 
Cordon-Cardo 1 
length 1 
//doi.org/dt5t 1 
antibodies.Almost 1 
laypeople 1 
coronavirusA 1 
gene-editing 1 
specialized 1 
equipment 1 8 
train 1 
personnel.Feng 1 
procedure 1 7 8 9 
reagent 1 
CRISPR-based 1 
protocol 1 2 3 4 5 
layperson 1 
access 1 2 3 4 8 9 
sous 1 
vide 1 
cooker 1 
kitchen 1 
commonly 1 2 3 
Joung 1 
//go.nature.com/35csgqk 1 
strip 1 
pregnancy 1 
office 1 
workplace 1 
necessary.6 1 
Speedy 1 
churn 1 
synthetic 1 7 
virusesResearchers 1 
yeast 1 
achieve.The 1 
Joerg 1 
Jores 1 
Volker 1 
Bern 1 
overlap 1 3 
stretch 1 8 
convert 1 
Thao 1 
//doi.org/ggttcr 1 
Saccharomyces 1 
cerevisiae 1 
stitch 1 
complete 1 2 3 4 5 9 
genome.The 1 
strand 1 
assemble 1 
say.5 1 
answerNew 1 
painful 1 
China.Marco 1 
Ajelli 1 
authority 1 
mandate 1 6 
stringent 1 
//doi.org/ggthtr 1 
drastic 1 
cities.The 1 
relieve 1 
hospitals.Another 1 
Shengjie 1 
Lai 1 
Southampton 1 
detection 1 2 4 
//doi.org/dtr4 1 
well.If 1 
epidemic-control 1 
delay 1 
higher 1 9 
found.4 1 
Portraits 1 
enzyme 1 4 5 9 
hunt 1 
drugsMolecular 1 
clue 1 
virus.Remdesivir 1 
RNA-dependent 1 
polymerase.A 1 
Patrick 1 
Cramer 1 
Max 1 
Planck 1 
Biophysical 1 
Chemistry 1 
Göttingen 1 
imaging 1 3 9 
cryo-electron 1 
Hillen 1 
//doi.org/dtgw 1 
post 1 4 5 
compounds.A 1 
Eric 1 
Xu 1 
Materia 1 
Medica 1 
solve 1 
snippet 1 
Yin 1 
//doi.org/dtnb 1 
COVID-19The 1 
differs 1 
ferret 1 
idea 1 
treatments 1 
COVID-19.Benjamin 1 
tenOever 1 
unusually 1 
Blanco-Melo 1 
//go.nature.com/3bWE82b 1 
controls.The 1 
imbalance 1 2 
replication 1 
less-specific 1 
inflammation.30 1 
COVID-19Children 1 
Shenzhen 1 
China.Justin 1 
Lessler 1 
Johns 1 
Hopkins 1 
Bloomberg 1 
Baltimore 1 6 
Tiejian 1 
Bi 1 
//doi.org/dtd7 1 
online 1 2 
//doi.org/dpf9 1 
original 1 
write.29 1 
hijack 1 
defencesThe 1 
interaction.To 1 
Alex 1 
Shalek 1 
Jose 1 2 
Ordovas-Montanes 1 
Ziegler 1 
//doi.org/ds9j 1 
tract.The 1 
flu 1 
switch 1 
ACE2.28 1 
Dry 1 
workaround 1 6 
test-chemical 1 
scarcityWide-scale 1 
shortage 1 3 
solution 1 4 
overcome 1 
difficulty 1 9 
Lea 1 
Starita 1 
Jay 1 
Shendure 1 
sought 1 
Srivatsan 1 
//doi.org/ds6k 1 
extraction-free 1 
correctly 1 4 
Conventional 1 
extraction 1 
enable 1 
scale-up 1 
self-collected 1 
centralize 1 
laboratories.27 1 
airborne 1 
RNAThe 1 
people.Ke 1 
Lan 1 
//doi.org/10.1038/s41586-020-2271-3 1 
elevated 1 3 
changing 1 
room 1 8 
disinfect 1 
Low 1 
well-ventilated 1 
wards.The 1 
routine 1 8 
disinfection 1 
spread.24 1 
Spit 1 
shortagesA 1 
accurately 1 
safer 1 
available.The 1 
rub 1 
sneeze 1 
barrage 1 
particles.Anne 1 
Wyllie 1 
//doi.org/ggssqf 1 
throat-swab 1 
Saliva 1 
infected.23 1 
Intensive 1 
Italian 1 7 
town.On 1 
Vo 1 
service 1 3 8 
commercial 1 2 
Andrea 1 2 
Crisanti 1 
lockdown.The 1 
Lavezzo 1 
//doi.org/ggsmcj 1 
infectiousness 1 
not.Asymptomatic 1 
strict 1 7 8 
say.22 1 
trialAn 1 
COVID-19.A 1 
Chuan 1 
Qin 1 
Peking 1 9 
Union 1 5 9 
Beijing 1 9 
chemically 1 
inactivated 1 
Gao 1 
//doi.org/dskt 1 
intentionally 1 
virus.All 1 
exposed 1 
approval 1 3 4 9 
it.20 1 
harsh 1 
restrictionsHong 1 
elsewhere.In 1 
attempt 1 8 
programme 1 
quarantining 1 
//doi.org/dsfw 1 
behavioural 1 
government 1 6 
found.17 1 
promiseA 1 
safe 1 3 5 
vaccine.Coronavirus 1 
bristle 1 
spiny 1 
recognizes 1 
attache 1 
cells.Hyeryun 1 
Choe 1 
Farzan 1 
Scripps 1 
Jupiter 1 
immunize 1 6 
rat 1 
Quinlan 1 
//doi.org/ggrs5t 1 
cells.Further 1 
vaccines.16 1 
Ski 1 
buff 1 
IcelandHolidaymakers 1 
ski 1 
Alps 1 
Iceland.In 1 
Kari 1 
Genetics-Amgen 1 
//doi.org/ggr6wx 1 
strain 1 
originate 1 
Austria 1 
Alpine 1 
resorts.Tests 1 
successful 1 
Iceland.15 1 
Relief 1 
unleash 1 
anewCases 1 
social-distancing 1 
models.Yonatan 1 
Grad 1 
Marc 1 2 
Lipsitch 1 
temperate 1 
S.M 1 
//doi.org/drz3 1 
year.If 1 
repeated 1 
wintertime 1 
say.15 1 
Common 1 3 
diagnosisA 1 
genomic-analysis 1 
COVID-19.In 1 
Schmid-Burgk 1 
barcode 1 
//doi.org/drzc 1 
High-speed 1 
instrument 1 
time.The 1 
anticipate 1 5 
million 1 
techniques.Correction 1 
name 1 
correspond 1 5 9 
Schmid-Burgk.10 1 
drugsScientists 1 
crystal 1 
protease 1 
cells.Hualiang 1 
Jiang 1 
Zihe 1 
Rao 1 
Haitao 1 
ShanghaiTech 1 
deposit 1 
ago 1 
//doi.org/10.1038/s41586-020-2223-y 1 
inhibitor 1 
ebselen 1 
people.These 1 
infiltrate 1 
hollow 1 
Proteases 1 
wide 1 2 5 
coronaviruses.9 1 
Absent 1 
responseAfter 1 
SARS-Cov-2 1 
undetectable.When 1 
foreign 1 
intrudes 1 
Jinghe 1 
Huang 1 
Fan 1 
novel 1 4 7 
//doi.org/dxb9 1 
rid 1 
infections.8 1 
illViral 1 
teams.Kwok-Yung 1 
Kong–Shenzhen 1 
peak.The 1 
excrete 1 
//doi.org/ggp4qx 1 
Zou 1 
//doi.org/ggmzsp 1 
.However 1 
admission 1 2 3 5 7 
//doi.org/dqrr 1 
Nanchang 1 
comparison 1 2 5 9 
subtle 1 
virusDoctors 1 
reverse-transcription 1 
qRT-PCR 1 
Nathan 1 
Grubaugh 1 
reliably 1 
//www.medrxiv.org/content/10.1101/2020.03.30.20048108v1 1 
.But 1 
third 1 8 
Charité–Universitätsmedizin 1 
samples.5 1 
Bats 1 
culpritViruses 1 
horseshoe 1 
bat 1 
ready 1 
decade 1 
maybe 1 
longer.David 1 
Boni 1 
//doi.org/10.1101/2020.03.30.015008 1 
Rhinolophus 1 
spp 1 
expand 1 8 
lineage 1 
ancestor 1 
split 1 9 
RaTG13 1 
humans.The 1 
directly 1 2 3 8 9 
specie 1 
straight 1 
human.3 1 
Masks 1 
virusSurgical 1 
effectively 1 
SARS-CoV-2.Seasonal 1 
enclosed 1 
booth 1 
sampling 1 9 
device 1 
Gesundheit-II 1 
capture 1 9 
Leung 1 
//doi.org/10.1038/s41591-020-0843-2 1 
coarse 1 
finer 1 
emit 1 
Mask 1 
Larger 1 
breath 1 2 
diameter 1 
micrometres 1 
less.The 1 
surgical 1 
influenza.Correction 1 
DNA.1 1 
llamas 1 
virusAntibodies 1 
llama 1 
Lama 1 
glama 1 
Bert 1 
Schepens 1 
Xavier 1 
Saelens 1 
VIB 1 
life-sciences 1 
Ghent 1 
Belgium 1 
McLellan 1 
Austin 1 
Wrapp 1 
//doi.org/10.1101/2020.03.26.010165 1 
Middle 1 
MERS 1 
mop 1 
coronavirus.Fusing 1 
Debilitated 1 
rally 1 
survivor 1 9 
bloodPeople 1 
improvement 1 3 4 5 9 
infusion 1 2 3 4 5 
teams.Both 1 
COVID-19.Xiaoming 1 
Engineering 1 6 
Combined 1 
sixth 1 
Duan 1 
//doi.org/dqrs 1 
.A 1 
Lei 1 
Third 1 
Shen 1 
//doi.org/dqn7 1 
Symptoms 1 
longer 1 8 
ventilators.Other 1 
like 1 
transfusion 1 2 
exposed.27 1 
treatmentsA 1 
list 1 2 4 5 
people.A 1 
Nevan 1 
Krogan 1 
Gordon 1 
//doi.org/10.1101/2020.03.22.002386 1 
physically 1 
proteins.Out 1 
disrupt 1 
collaborator 1 
urge 1 6 
AbstractBACKGROUNDTherapies 2 
interrupt 2 
Covid-19 2 3 4 5 6 
elusive 2 
convalescent 2 5 9 
unsuccessful 2 
earlier 2 
illness.METHODSWe 2 
placebo-controlled 2 3 4 5 
IgG 2 4 9 
titer 2 4 
primary 2 3 4 5 9 
define 2 4 5 9 
saturation 2 3 
ambient 2 3 
projected 2 
considerably 2 6 
steady 2 
enrollment 2 3 4 5 
virtually 2 
impossible.RESULTSA 2 
underwent 2 3 4 5 9 
randomization 2 3 4 5 
intention-to-treat 2 3 
confidence 2 3 4 5 
[ 2 3 4 5 9 
CI 2 3 4 5 9 
] 2 3 4 5 9 
P=0.03 2 
end-point 2 
solicited 2 
adverse 2 3 4 5 
observed.CONCLUSIONSEarly 2 
administration 2 6 
high-titer 2 
Funded 2 3 4 5 
Bill 2 
Melinda 2 
Gates 2 
Pandemic 2 
Fund 2 9 
Dirección 2 
Sangre 2 
Medicina 2 
Transfusional 2 
Ministerio 2 
Salud 2 
PAEPCC19 2 
Plataforma 2 
Registro 2 
Informatizado 2 
Investigaciones 2 
ClinicalTrials.gov 2 3 4 5 
NCT04479163 2 
tab 2 3 4 5 
etiologic 2 
group.1,2 2 
Various 2 
coexist 2 3 5 6 
adversely 2 
prognosis 2 
regardless 2 4 
hypertension 2 5 9 
obesity 2 5 
chronic 2 5 7 9 
renal 2 9 
obstructive 2 9 
pulmonary 2 7 9 
COPD 2 
.1,2Treatments 2 
Few 2 
evaluated.3-12 2 
patients.7-12 2 
Plasma 2 9 
events13 2 
improved 2 
diseases.14-16 2 
effective.14-16In 2 
hospitalized 2 3 4 5 
consequently 2 
appropriate 2 9 
unclear.7-12 2 
evaluate 2 3 4 5 9 
efficacious 2 3 5 
Covid-19. 2 5 
MethodsTRIAL 2 3 4 5 
DESIGN 2 3 5 
AND 2 3 4 5 
OVERSIGHTWe 2 3 
randomize 2 3 4 5 
geriatric 2 
unit 2 3 8 9 
Argentina 2 
institutional 2 3 4 
board 2 3 4 
participating 2 
institution 2 7 
supervise 2 
manuscript 2 3 4 9 
Table 2 3 4 5 
S15 2 
Supplementary 2 3 4 5 
Appendix 2 3 4 5 
full 2 3 4 5 9 
text 2 3 4 5 
NEJM.org 2 3 4 5 
vouch 2 3 4 
completeness 2 3 4 
adherence 2 
analyze 2 4 
draft 2 3 9 
writing 2 9 
confidentiality 2 4 
agreement 2 4 
sponsor 2 3 5 
institutions.TRIAL 2 
PATIENTSPatients 2 
irrespective 2 
coexisting 2 3 6 
eligibility 2 
Coexisting 2 
S1 2 3 4 5 
currently 2 7 
pharmacologic 2 5 
reverse-transcriptase–polymerase-chain-reaction 2 4 5 
RT-PCR 2 4 5 
eligible 2 3 4 9 
category 2 3 9 
unexplained 2 
sweating 2 
chill 2 
dyspnea 2 
myalgia 2 
anorexia 2 
sore 2 
dysgeusia 2 
anosmia 2 
rhinorrhea 2 
Exclusion 2 
S5 2 3 4 
both.Patients 2 
consent 2 3 4 7 9 
nasopharyngeal 2 4 5 7 
oropharyngeal 2 
secretion 2 5 
obtain 2 4 5 7 9 
iAMP 2 
Atila 2 
BioSystems 2 
Patients 2 3 4 5 9 
invite 2 9 
informed-consent 2 
legal 2 
guardian 2 
cognitive 2 
impairment 2 9 
Starting 2 
transform 2 
low-complexity 2 
inpatient 2 8 9 
invited 2 
participate 2 3 4 7 9 
on-site.RANDOMIZATION 2 
INTERVENTIONEligible 2 
informed 2 3 4 7 
ml 2 
S 2 9 
COVIDAR 2 
Instituto 2 
Leloir 2 
saline 2 4 
arbitrarily 2 
percentile 2 
computer-generated 2 
balanced 2 8 
permuted 2 
prepare 2 3 
center.Convalescent 2 
conceal 2 
opaque 2 
bag 2 
tape 2 
cover 2 
catheter 2 
intervention.A 2 
minimum 2 
tests17 2 
Potential 2 
adequate 2 5 6 
Fig 2 3 4 5 
S6 2 3 4 
.CLINICAL 2 4 
LABORATORY 2 
MONITORINGA 2 
venous 2 7 9 
Serum 2 
preserve 2 
−20°C 2 
completion 2 4 
anti–S 2 
addition 2 3 4 
S1-RBD 2 
enzyme-linked 2 9 
immunosorbent 2 9 
kit 2 
GenScript 2 
surrogate 2 5 
neutralization 2 4 5 
physician 2 3 4 9 
discharge 2 3 9 
Figs 2 4 
S7 2 3 4 
S8 2 3 
warrant 2 
resolution 2 9 
maximum 2 3 
predesigned 2 
questionnaire 2 5 7 9 
Data 2 3 5 9 
double-entered 2 
electronic 2 9 
database.TRIAL 2 
END 2 
POINTSThe 2 
participation.Prespecified 2 
supplementation 2 
inspired 2 
Fio2 2 
noninvasive 2 3 
critical 2 3 4 6 
systemic 2 3 7 
ratio 2 3 7 9 
partial 2 
pressure 2 3 
≤200 2 
mm 2 9 
Hg 2 
shock 2 
resolve 2 5 9 
participation 2 3 4 
amend 2 
fourth 2 
combination.EARLY 2 
TRIAL 2 
TERMINATIONThe 2 
initiate 2 4 
approximately 2 4 5 9 
goal 2 
Consequently 2 4 
discussion 2 
logistically 2 
ethically 2 
questionable 2 
results.STATISTICAL 2 
ANALYSISGiven 2 
complexity 2 
intervention 2 5 9 
minimal 2 4 
clinically 2 5 
expected 2 
between-group 2 3 
significance 2 3 
α=0.05 2 
two-sided 2 3 5 9 
z-test 2 
continuity 2 
correction 2 
plan 2 4 5 6 8 
interim 2 3 4 5 
Brien–Fleming 2 
spending 2 
function 2 9 
boundaries.In 2 
Continuous 2 
variable 2 4 9 
deviation 2 
interquartile 2 
categorical 2 9 
percentages.In 2 
Kaplan–Meier 2 3 
product 2 
ineligible 2 
prespecified 2 4 
evaluation 2 3 5 9 
subgroup 2 3 4 5 9 
condition. 2 
ResultsTRIAL 2 
POPULATIONA 2 
Hypoxemia 2 
analysis.A 2 
voluntarily 2 
Characteristics 2 
Intention-to-Treat 2 3 
Population.The 2 3 
±SD 2 3 4 
baseline 2 3 4 5 9 
characteristic 2 3 4 9 
.PRIMARY 2 3 
POINTTable 2 
2.Trial 2 
End 2 4 
Points 2 
Population.Figure 2 3 
Development 2 4 9 
Respiratory 2 3 9 
Due 2 
According 2 3 5 
Trial 2 3 5 9 
Analysis.In 2 
Figure 2 3 4 5 
time-to-event 2 3 
episode 2 9 
S2 2 3 4 
.SECONDARY 2 5 
POINTSSecondary 2 
respectively 2 3 4 5 
combined 2 4 
Secondary 2 3 
S10.ANTIBODY 2 
TITERSFigure 2 
2.SARS-CoV-2 2 4 5 
Titers 2 
Group.The 2 
anti–SARS-CoV-2 2 4 
significantly 2 3 7 9 
log 2 5 
S5B 2 
.Table 2 4 
3.Primary 2 
Point 2 
Donor 2 
Titer.Conversely 2 
dose-dependent 2 
worsening 2 7 
alternative 2 7 
selection 2 3 5 
r=0.7 2 
S3 2 3 4 
DiscussionWe 2 
discern 2 
respect 2 3 
approach 2 3 4 6 8 
facilitate 2 
selection.Our 2 
fundamental 2 6 
S14 2 
.7-11 2 
affected 2 
pandemic.1,2 2 
Previous 2 
older.7-11 2 
trials.7-11Studies 2 
admission,8 2 
U.S. 2 6 
multicenter 2 4 
later.12 2 
Recently 2 
Attachment 2 5 
Entry 2 5 
Neutralizing 2 5 
BLAZE-1 2 5 
outpatient 2 4 5 7 9 
mild-to-moderate 2 7 9 
Covid-19.18,19 2 
Access 2 
low- 2 
middle-income 2 
per-patient 2 
dollar 2 
S13 2 
effects.In 2 
aware 2 4 
trial-group 2 
hemotherapy 2 
station 2 
mile 2 
security 2 
challenge 2 7 8 
preclude 2 3 
p.m. 2 
exclusion 2 4 5 
efficacy 2 3 4 5 6 
Again 2 
efficacy.Our 2 
exploratory 2 3 5 
ingredient 2 
Super 2 
immunized 2 
future 2 4 5 9 
arsenal 2 
donations.20In 2 
bridge 2 
at-risk 2 
available. 2 
Supported 2 4 5 
contribution 2 
Laboratorio 2 
Roemmers 2 
Bodega 2 
Vistalba 2 
Laboratorios 2 
Bago 2 
Raffo 2 
Monserrat 2 
Eclair 2 
Tuteur 2 
Sacifia 2 
TASA 2 
Logistica 2 
Inversiones 2 
Representaciones 2 
Puerto 2 
Asís 2 
Investments 2 
Hematológica 2 
Sarmiento 2 
Alec 2 
Oxenford 2 
Kulish 2 
Renato 2 
Montefiore 2 
Irene 2 
Gorodisch 2 
Alejandro 2 
Agustín 2 
Otero-Monsegur 2 
Luis 2 
Otero.Disclosure 2 
NEJM.org.Drs 2 5 
Pérez 2 
article.This 2 5 
NEJM.org.A 2 4 5 
statement 2 4 5 
NEJM.org.We 2 4 5 
thank 2 4 5 9 
Ana 2 
Ayrolo 2 
Paula 2 
Cipriani 2 
Veronica 2 
Bianchi 2 
Omar 2 
Lavieri 2 
Cecilia 2 
Riera 2 
Sala 2 
Carola 2 
Candurra 2 
Roxana 2 
Olivera 2 
Emiliano 2 
Sosa 2 
Sergio 2 
Maldonado 2 
Ariel 2 
Guzman 2 
Gollan 2 
Fernan 2 
Quiros 2 
Luana 2 
Volnovich 2 
Aimar 2 
Mariana 2 
Bertolini 2 
Manuela 2 
Bermudez 2 
Prudent 2 
Stamboulian 2 
Juan 2 
Rey 2 
Liste 2 
Cristian 2 
Werb 2 
Sebastian 2 
Crespo 2 
Joaquin 2 
Larrabide 2 
Anigstein 2 
Adrian 2 
Galloso 2 
Parrilla 2 
Manuel 2 
Debatista 2 
Sandra 2 
Lobosco 2 
Martin 2 
Donghi 2 
Gerry 2 
Garbulsky 2 
Alan 2 
Gegenschatz 2 
Marcelo 2 
Kamijo 2 
Luciana 2 
Armengol 2 
Adriana 2 
Romeo 2 
Alejandra 2 
Castro 2 
Alfredo 2 
Monte 2 
Rosa 2 
Chiaro 2 
Stilman 2 
Argüello 2 
Churba 2 
Di 2 
Fabio 2 
Gonzalez 2 
Chicote 2 
Hardoy 2 
Vairo 2 
Fernandez 2 
Parmo 2 
Masdeu 2 
Picciola 2 
Darío 2 
Ibañez 2 
Enriqueta 2 
Chmielecki 2 
Estela 2 
Kalinsky 2 
Fabian 2 
Galperin 2 
Felisa 2 
Rodríguez 2 
Palma 2 
Florencia 2 
Martinez 2 
Pedemonte 2 
Raúl 2 
Gómez 2 
Gabriela 2 
Lombardi 2 
Gisela 2 
Kremenchuzky 2 
Gustavo 2 
Rizzo 2 
Nelson 2 
Donato 2 
Iván 2 
Urlich 2 
Cohen 2 
Jorge 2 
Aguirre 2 
Jorgelina 2 
Centeno 2 
Redondo 2 
Leandro 2 
Stitzman 2 
Arias 2 
Marcela 2 
Baldoni 2 
Oksengendler 2 
Testoni 2 
Suarez 2 
Mercedes 2 
Solis 2 
Levy 2 
Eugenia 2 
Segretin 2 
Sotti 2 
Laura 2 
Alzúa 2 
Nora 2 
Etchenique 2 
Soledad 2 
Oporto 2 
Dunaiewsky 2 
Loban 2 
Marta 2 
Wydra 2 
Miguel 2 
Patane 2 
Mirta 2 
Ludueña 2 
Natalia 2 
Gitelman 2 
Pablo 2 
Lopez 2 
Rush 2 
Pini 2 
Figoni 2 
Prado 2 
Jiménez 2 
Silvana 2 
Franco 2 
Silvina 2 
Bosco 2 
Moreno 2 
Vallieri 2 
Valeria 2 
Rios 2 
Siciliano 2 
Verónica 2 
Zlotogorski 2 
Raul 2 
Gaivironsky 2 
Minatta 2 
Grupo 2 
Pediátrico 2 
Militar 2 
Central 2 
invaluable 2 
Drs 2 
Gilda 2 
Piaggio 2 
Hevia 2 
Roberto 2 
Freue 2 
AbstractBACKGROUNDCoronavirus 3 
hyperinflammation 3 
underserved 3 
racial 3 
anti–interleukin-6 3 
unclear.METHODSWe 3 
mechanical 3 9 
mg 3 4 5 
kilogram 3 5 
intravenously 3 4 
Site 3 
Hispanic 3 4 
Latino 3 4 
Black 3 4 
Indian 3 
Alaska 3 
Native 3 
non-Hispanic 3 
White 3 5 
cumulative 3 5 7 
hazard 3 
P=0.04 3 
log-rank 3 
favor 3 
Death 3 
weighted 3 
–﻿5.2 3 
group.CONCLUSIONSIn 3 4 5 
composite 3 5 
improve 3 4 5 6 
survival 3 4 
Genentech 3 
EMPACTA 3 
NCT04372186 3 
emergency.1,2 3 
Covid-19–associated 3 
distress 3 5 7 8 
syndrome.3,4 3 
Covid-19.5,6Patients 3 
mainstay 3 
supportive9 3 
far.10Therapies 3 
disproportionately 3 6 
pandemic.11-19 3 
Covid-19–Associated 3 
Hospitalization 3 
Surveillance 3 
defined 3 
persons.12 3 
non-White 3 
Covid-19–related 3 4 5 
patients.13 3 
Greater 3 
recruitment 3 
underrepresented 3 
trials.20Covid-19 3 
dysregulated 3 
exacerbate 3 
multiorgan 3 
failure.4,21,22 3 
interleukin-6 3 
positively 3 9 
disease23,24 3 
predictive 3 
ventilation.25 3 
Tocilizumab 3 
diseases26,27 3 
observational 3 
globally.28-30 3 
background 3 
care.31-34In 3 
Evaluating 3 
Minority 3 
Actemra 3 
emphasized. 3 
Global 3 
enhance 3 4 
understanding 3 4 
represent 3 7 8 9 
Details 3 5 
Methods 3 5 
section 3 4 5 
NEJM.org.Patients 3 
polymerase-chain-reaction 3 
radiographic 3 
continuous 3 9 
bilevel 3 
limited 3 6 7 8 9 
glucocorticoid 3 
≤1 3 
methylprednisolone 3 
supportive 3 
imminent 3 
inevitable 3 
treating 3 
tuberculosis 3 
suspect 3 7 
bacterial 3 
fungal 3 
well-controlled 3 
immunodeficiency 3 
investigator 3 4 5 
trial.Each 3 
legally 3 
representative 3 
witness 3 
oral 3 7 
accordance 3 4 5 
International 3 4 5 
Conference 3 
Harmonisation 3 4 
E6 3 
guideline 3 4 5 6 
Practice 3 4 
Declaration 3 4 5 
Helsinki 3 4 5 
regulation 3 
whichever 3 
afford 3 
Advarra 3 
Institutional 3 
Review 3 
Board 3 
Western 3 
ethic 3 4 
committee 3 4 
contract 3 4 
organization 3 
pay 3 
manage 3 4 9 
direction 3 
supervision 3 
fidelity 3 4 
editorial 3 5 
assistance 3 4 
fund 3 
sponsor.Using 3 
permuted-block 3 
interactive 3 
voice- 3 
Web-response 3 
intravenous 3 4 5 9 
stratify 3 9 
Mexico 3 
blinding 3 
worsen 3 4 9 
sustain 3 
seven-category 3 9 
ordinal 3 
scale 3 4 9 
one.Efficacy 3 
MEASURESThe 3 
extracorporeal 3 9 
membrane 3 9 
oxygenation 3 9 
geographic 3 
received.The 3 
28-day 3 
readiness 3 
two-category 3 
threshold 3 5 
ICU 3 9 
withdrawal 3 
death.The 3 
Terminology 3 
Criteria 3 
Adverse 3 4 
Events 3 4 
ANALYSISThe 3 4 
modify 3 4 
Efficacy 3 
Analyses 3 
curve 3 4 
stratified 3 9 
Cox 3 
proportional-hazards 3 
censor 3 
first.The 3 
hierarchical 3 
manner 3 4 
trial-wide 3 
error 3 4 
predefined 3 
death.Time-to-event 3 
Deaths 3 
charge 3 
discontinue 3 
ordinal-scale 3 
Cochran–Mantel–Haenszel 3 
adjustment 3 9 
adjust 3 4 9 
multiplicity 3 4 
Sensitivity 3 
compete 3 6 7 8 9 
Information 3 
regard 3 4 5 9 
verification 3 
Appendix.Safety 3 
internal 3 
committee. 3 
ResultsPATIENTSFigure 3 5 
Randomization 3 4 
Follow-up.Overall 3 
Overall 3 4 
groups.Table 3 
Baseline 3 4 5 
demographic 3 9 
balance 3 4 5 8 
S4 3 4 
EFFICACY 3 
OUTCOMETable 3 5 
Key 3 4 5 9 
Outcomes 3 
Day 3 5 
Mechanical 3 
Ventilation 3 
Results 3 4 
OUTCOMESThe 3 
–5.2 3 
S6.SAFETYTable 3 
Safety 3 4 
cutoff 3 4 
S9 3 
S10 3 
scale. 3 
DiscussionOur 3 
trials.11-20 3 
group.This 3 
fact 3 7 
Studies 3 
shorter 3 
range.Health 3 
disparity 3 
complex 3 8 
historical 3 
inequity 3 
observation 3 4 5 
needed.14,16,19,35 3 
discrepancy 3 
overrepresentation 3 
underrepresentation 3 
trials,20 3 
enroll 3 4 5 
population.Prevention 3 
greatly 3 
availability 3 7 
resource 3 
in-hospital 3 
.8 3 
making 3 
globally 3 
conserve 3 
resource36 3 
Africa.37 3 
Decreasing 3 
burden 3 4 5 8 
patients.38The 3 
COVACTA31 3 
Area 3 
Consortium 3 
BACC 3 
Bay 3 
Tocilizumab34 3 
COVACTA 3 
hypoxia 3 
stage.31 3 
scale.34As 3 
RCT-TCZ-COVID-19 3 
CORIMUNO-TOCI-1 3 
trials,31-34 3 
concomitant 3 9 
Covid-19.39 3 
uniformly 3 
reflect 3 
up-to-date 3 
Glucocorticoid 3 
added 3 
respectively.31 3 
trial.The 3 
groups.33 3 
trial.31,32,34 3 
mortality.The 3 
Ongoing 3 
clarity 3 
immunomodulatory 3 
therapies.Our 3 
AbstractBACKGROUNDRecent 4 
loads.METHODSIn 4 
ongoing 4 5 7 
nonhospitalized 4 5 
REGN-COV2 4 
emergence 4 
treatment-resistant 4 
mutant 4 
g 4 
prospectively 4 5 
endogenous 4 
antibody–positive 4 
antibody–negative 4 
time-weighted 4 
medically 4 
patients.RESULTSData 4 
least-squares 4 
−0.56 4 
log10 4 
milliliter 4 5 
−1.02 4 
−0.11 4 5 
−0.41 4 
−0.71 4 
−0.10 4 
attended 4 
corresponding 4 9 
−9 4 
−29 4 
hypersensitivity 4 
infusion-related 4 
Biomedical 4 
Advanced 4 
Authority 4 
Human 4 
Services 4 
NCT04425629 4 
causative 4 
loads,2-5 4 
hypoxemia 4 
develops 4 
receipt 4 
oxygen.6-8 4 
pathogenesis 4 9 
hyperresponse 4 
infection9 4 
immunomodulating 4 
results.10-13 4 
patients,14 4 
SARS-CoV-2–neutralizing 4 
emanate 4 
noncompeting 4 
IgG1 4 
thereby 4 
angiotensin-converting 4 5 
receptor.15,16 4 
pursue 4 
suptavumab 4 
syncytial 4 
virus.17 4 
Preclinical 4 
antibody.15 4 
vivo 4 
nonhuman 4 5 
primate 4 5 
profound 4 7 8 
prophylactic 4 
context 4 8 
clearance 4 5 
context.18We 4 
hypothesize 4 
native 4 
humoral 4 
exogenously 4 
preexist 4 
entry.Here 4 
infection. 4 
DESIGNWe 4 
operationally 4 
seamless 4 
continual 4 
refine 4 
casirivimab 4 
REGN10933 4 
imdevimab 4 
REGN10987 4 
equal 4 
cocktail.Details 4 
stratification 4 
pharmacokinetic 4 
phases.PATIENTSTo 4 
SARS-CoV-2–positive 4 
NEJM.org.An 4 
serologic 4 
IgA 4 9 
anti-S1 4 
anti-nucleocapsid 4 
borderline 4 
here.INTERVENTION 4 
ASSESSMENTSAt 4 
250-ml 4 
schedule 4 8 
summary 4 
amendment 4 
Quantitative 4 
virologic 4 5 
Appendix.END 4 
POINTSMultiple 4 
priori 4 
unblinded 4 
formal 4 
performed.The 4 
absolute 4 5 9 
hoc 4 5 
point.The 4 
Medically 4 
telemedicine 4 7 
department 4 5 
hospitalization.For 4 
grade 4 5 
interest 4 6 7 9 
Pharmacokinetic 4 
time.TRIAL 4 
OVERSIGHTRegeneron 4 
vouches 4 
feedback 4 
final 4 8 9 
submission 4 
Regeneron.The 4 
personnel 4 
unaware 4 
treatment-group 4 
periodically 4 
recommendation 4 6 
modification 4 
termination 4 
separately 4 
design.The 4 
applicable 4 5 9 
regulatory 4 
center 4 5 6 
oversee 4 
documentation 4 
violation 4 
collection 4 9 
withdraw 4 
trial.STATISTICAL 4 
presented 4 
finalize 4 
unblinding 4 
trend 4 5 
purpose 4 
qualitative 4 
population.The 4 7 
calculate 4 9 
concentration–time 4 
linear 4 9 
trapezoidal 4 
analysis-of-covariance 4 
group–by–baseline 4 
covariates 4 
Confidence 4 
Statistical 4 
SAS 4 9 
software 4 9 
Appendix. 4 
ResultsBASELINE 4 
CHARACTERISTICSFigure 4 
Treatment.Of 4 
received 4 
high-dose 4 
low-dose 4 7 
Characteristics.The 4 
i.e. 4 
S1.NATURAL 4 
HISTORYAny 4 
properly 4 
Covid-19.Table 4 
Virologic 4 
Points.The 4 
raw 4 
retrospective 4 
subgroup.VIROLOGIC 4 
EFFICACYThe 4 
−0.52 4 
−1.04 4 5 
−0.60 4 
−1.12 4 5 
−0.08 4 5 
−0.25 4 
−0.91 4 
−0.21 4 
respectively.Figure 4 
Load 4 5 
Time.Additional 4 
> 4 
Similar 4 
covariate-adjusted 4 
unadjusted 4 
2-log 4 
evident 4 
−3 4 
−16 4 
descriptive 4 
set19 4 
alleviation 4 
unpublished 4 
.SAFETYTable 4 
3.Serious 4 
Special 4 
Interest 4 
Population.In 4 
mainly 4 9 
low-grade 4 
toxic 4 
groups.PHARMACOKINETICSThe 4 
dose-proportional 4 
pharmacokinetics 4 
liter 4 
DiscussionTo 4 
loads.14,20 4 
response.21 4 
prospective 4 
treatment.Our 4 
.As 4 
exogenous 4 
impede 4 
status.Higher 4 
patients.22 4 
High-titer 4 
convalescent-phase 4 
lower 4 5 
Covid-19.23,24 4 5 
Likewise 4 
achievable 4 
quantifiable 4 
presumably 4 
testable 4 
elimination 4 5 
NCT04452318 4 
Similarly 4 
symptomatology 4 
observed.The 4 
antidrug-antibody 4 
altered 4 
due 4 7 8 9 
antidrug 4 
predicted 4 9 
vitro 4 
preclinical 4 5 
half-life 4 
passive 4 5 
REGN-COV2.An 4 
limitation 4 9 
rigorously 4 
trial.Similar 4 
SARS-CoV-2.25 4 
Ebola 4 
Further 4 9 
effects. 4 
HHSO100201700020C 4 
.Disclosure 4 
NEJM.org.This 4 
update 4 
investigational 4 
principal 4 
subprincipal 4 
Balachandra 4 
Dass 4 
Ph.D. 4 5 
Caryn 4 
Trbovic 4 
Brian 4 
Head 4 
Prime 4 
format 4 
editing 4 
suggestion 4 
AbstractBACKGROUNDSevere 5 
Virus-neutralizing 5 
ameliorate 5 
hospitalization.METHODSIn 5 
LY-CoV555 5 
preplanned 5 
observed 5 9 
−3.81 5 
2800-mg 5 
−0.53 5 
−0.98 5 
P=0.02 5 
Smaller 5 
700-mg 5 
−0.20 5 
−0.66 5 
P=0.38 5 
7000-mg 5 
−0.37 5 
P=0.70 5 
accelerate 5 9 
NCT04427501 5 
Infected 5 
hospitalization.1 5 
underlie 5 9 
,2,3 5 
connection 5 
longitudinal 5 9 
Several 5 
option 5 
e.g. 5 
drugs,4 5 
agents,5-7 5 
immunomodulators,8-12 5 
glucocorticoids,13,14 5 
plasma15,16 5 
targeted 5 
intend 5 8 
attenuate 5 
disease.Preclinical 5 
neutralizing-antibody 5 
marked 5 
tracts.17 5 
cells.18 5 
LY3819253 5 
affinity 5 
derive 5 
AbCellera 5 
previously.19Here 5 
persistently 5 
severity. 5 
TREATMENT 5 
OVERSIGHTIn 5 
single-dose 5 
monotherapy 5 
feature 5 7 9 
modeling 5 
Given 5 
gravity 5 
coverage 5 
Dose 5 
fix 5 
testing.The 5 
ethical 5 
Organizations 5 
Sciences 5 6 9 
consent.OUTCOMESThe 5 
±4 5 
in-patient 5 
refer 5 
adverse-event 5 
outcomes.STATISTICAL 5 
ANALYSISTo 5 
dynamic 5 9 
simulate 5 
simulated 5 
Section 5 
document 5 9 
undergone 5 
baseline.Treatment 5 
alpha 5 
Adjustments 5 
Significance 5 
repeated-measures 5 
Design.Table 5 
Baseline.From 5 
body-mass 5 
index 5 
BMI 5 
height 5 
meter 5 9 
relevant 5 8 
Ct 5 
match 5 
expectation 5 
conversion 5 
plan.PRIMARY 5 
Load.By 5 
substantial 5 6 
VIRAL 5 
OUTCOMESOn 5 
−0.64 5 
−1.11 5 
−0.17 5 
−0.42 5 
−0.89 5 
−0.90 5 
pooled 5 
−0.49 5 
−0.87 5 
MEASURES 5 
OF 5 
CLEARANCEFigure 5 
stratum 5 
box 5 
plot 5 9 
N1 5 
primer 5 
nucleic 5 
acid–based 5 
amplification 5 
reference 5 
panel 5 8 
probability 5 
indicated 5 
7.COVID-19–RELATED 5 
HOSPITALIZATIONTable 5 
unit.SYMPTOM 5 
SCOREFigure 5 
Scores 5 
−0.79 5 
−1.35 5 
−0.24 5 
−0.57 5 
−0.01 5 
−1.60 5 
−0.73 5 
−1.28 5 
−0.23 5 
symptoms.SAFETYTable 5 
Events.Serious 5 
Diarrhea 5 
vomiting 5 
nausea 5 
diarrhea 5 
Infusion-related 5 
pruritus 5 
flushing 5 
rash 5 
facial 5 
swell 5 
vital 5 9 
antihistamine 5 
symptoms.We 5 
resistance-associated 5 
Accordingly 5 
allele 5 
known. 5 
DiscussionIn 5 
biomarkers 5 
death.Among 5 
decreased 5 9 
meaningful 5 8 
disease.20,21 5 
accurate 5 
absence 5 7 8 
replication-competent 5 
primarily 5 
reflection 5 
practical 5 
precaution 5 
pragmatic 5 
course.An 5 
unanticipated 5 
delayed 5 
disease.20,22,23 5 
hospitalization.To 5 
≥65 5 
≥35 5 
group.The 5 
validity 5 
mechanistic 5 
accelerated 5 
Nevertheless 5 
placebo-treated 5 
pronounced 5 
Lilly.Disclosure 5 
Nirula 5 
Clooney 5 
medical-writing 5 
manuscript. 5 
Author 5 
AffiliationsFrom 5 
Guild 5 
Lung 5 9 
Cedars–Sinai 5 
Los 5 
Angeles 5 
P.C 5 
Long 5 
Beach 5 
Trials 5 
B.H 5 
A.N. 5 
A.C.A. 5 
J.V.N. 5 
K.L.C. 5 
L.S. 5 
M.D. 5 
G.O. 5 
A.E.S. 5 
J.S. 5 
D.R.P. 5 
P.K. 5 
D.M.S 5 
Franciscan 5 
Greenwood 5 
I.S 5 
Scott 5 
Dallas 5 
R.L.G 5 
Vitalink 5 
SC 5 
J.B. 5 
Charles 5 
LA 5 
J.M 5 
Cook 5 
G.H 5 
Feinberg 5 
V.S 5 
Chicago 5 
Indago 5 
Hialeah 5 
FL 5 
J.C. 5 
Las 5 
Vegas 5 
B.M 5 
.Address 5 
reprint 5 
Dr. 5 
Skovronsky 5 
Delaware 5 
IN 5 
skovronsky_daniel 5 
@ 5 
lilly.com.A 5 
devastate 6 
refugee 6 
asylum 6 
seeker 6 
federal 6 
detention 6 
optimism 6 
Pfizer 6 
task 6 
force 6 8 
prioritizing 6 
detainee 6 
immunization 6 
devise 6 
jeopardize 6 
prospect 6 
endanger 6 
population.Under 6 
migrant 6 
hot 6 
spot 6 
measles 6 
mumps 6 
Investigations 6 
gross 6 
negligence 6 
disturbing 6 
expertise 6 
detainees.1 6 
unsurprising 6 
living 6 
inadequate 6 
sanitation 6 
capacity 6 9 
Customs 6 
Border 6 
CBP 6 
reject 6 
cite 6 
logistic 6 9 
difficulties. 6 
refuse 6 8 
CDC 6 
infection-evaluation 6 
detainment 6 
centers.3 6 
nonadherence 6 
extraordinarily 6 
positivity 6 9 
Immigration 6 
Enforcement 6 
ICE 6 
exceed 6 
centers.4A 6 
Academies 6 
NASEM 6 
framework 6 
allocation 6 
teacher 6 
homeless 6 
shelter 6 9 
conditions.5 6 
prioritization 6 
acknowledge 6 
devastation 6 
detained 6 
responsibility 6 8 9 
care.However 6 
Operation 6 
Warp 6 
Speed 6 
distribute 6 
Individual 6 
allotted 6 
heft 6 
crush 6 
lot 6 
entity 6 
proven 6 
Louisiana 6 
explicitly 6 9 
mention 6 
plan.5 6 
incarcerated 6 
immunization.Leaving 6 
implementation 6 
proximity 6 
believe 6 
vaccination.2The 6 
deny 6 
right 6 
incoming 6 
Biden 6 
indication 6 
aside 6 
immigration 6 
provision 6 
Vaccinating 6 
medicine 6 
humane 6 
disenfranchised 6 
allocate 6 
them. 6 
Carlo 6 
Foppiano 6 
Palacios 6 
M.D.Yale 6 
CTMark 6 
Travassos 6 
M.D.University 6 
MD 6 
β-coronavirus 7 
management 7 
comorbidities,1 7 
rheumatic 7 
diseases.3 7 
non-negligible 7 
characterise 7 9 
susceptibility 7 
aggravate 7 
immune-modulating 7 
therapies.Among 7 
vasculitis 7 
ie 7 9 
arthritis.4 7 
Systemic 7 
sclerosis 7 
multi-organ 7 
involvement 7 9 
concomitancy 7 
fibrosing 7 
microvascular 7 
alterations.7 7 
literature 7 
impact 7 
anecdotal 7 
single-centre 7 
miscellanea 7 
disorders.4 7 
9Following 7 
compromise 7 8 
regular 7 
immunocompromised 7 
Between 7 
macro-areas 7 
north 7 
medium 7 
south 7 
unselected 7 
consecutively 7 
telephone 7 9 
tertiary 7 
referral 7 
southern 7 
6-week 7 
serological 7 
interview 7 9 
standardised 7 
described.4COVID-19 7 
definite 7 
suggestive 7 
virological 7 
.4The 7 
appendix 7 9 
pp 7 9 
SD 7 
cutaneous 7 
sine 7 
scleroderma 7 
sclerosis-related 7 
interstitial 7 9 
cardiomyopathy 7 
anti-Scl70 7 
anticentromere 7 
Moreover 7 8 
conventional 7 
disease-modifying 7 
antirheumatic 7 
vasoactive 7 
iloprost 7 
prostanoids 7 
bosentan 7 
calcium 7 
channel 7 
blocker 7 
aspirin 7 
individuals.After 7 
p 7 9 
invariably 7 
p=0·0010 7 
Superior 7 
updated 7 
conversely 7 
overestimate 7 
Piemonte 7 
Veneto 7 
Emilia 7 
Romagna 7 
Liguria 7 
Campania 7 
Molise 7 
Puglia 7 
Calabria 7 
Sicily 7 
p=0·0030 7 
moreover 7 
.Clinically 7 
manifestation 7 9 
Unfortunately 7 
died 7 
42-year-old 7 
cardiopulmonary 7 
65-year-old 7 
fibrosis 7 9 
complicate 7 8 
arterial 7 
thrombotic 7 
embolic 7 
stroke.Definite 7 
< 7 9 
appearance 7 
exception 7 8 
p=0·0060 7 
.Taken 7 
noteworthy 7 
pathological 7 
implication 7 
multifactorial 7 9 
multistep 7 
aetiopathogenetic 7 
process 7 
whereby 7 
epigenetic 7 
environmental 7 
phenotype 7 
outcome.7 7 
Notably 7 9 
endothelial 7 
diffuse 7 
microangiopathy.7 7 
sclerosis.These 7 
pathogenic 7 
previously.7 7 
virus-related 7 
hypothesise 7 
amplify 7 8 
advanced 7 
Long-term 7 9 
series 7 9 
clarify 7 9 
In-depth 7 
compromised 7 
insight 7 
sclerosis.Given 7 
unpredictable 7 
threatening 7 
prevention 7 8 
advisable.We 7 
declare 7 9 
agree 7 9 
organisation 8 
visiting 8 
dying 8 
midst 8 
compel 8 
loved 8 
infection.Hospital 8 
Restrictions 8 
harm 8 
separation 8 
Exemptions 8 
compassionate 8 
transmission.It 8 
grief 8 
bereavement 8 
pandemics.1 8 
restrictive 8 
delirium 8 
anxiety 8 9 
patients.2 8 
rite 8 
disruption 8 
network 8 
Virtual 8 
communication 8 
feasible 8 
dyspnoeic 8 
delirious 8 
liberalise 8 
Liberal 8 
nosocomial 8 
burnout 8 
staff.2 8 
Zhou 8 
colleagues4 8 
personal 8 9 
scarcity 8 
frustrating 8 
precise 8 
psychomorbidity 8 
justify 8 
ever 8 
outbreaks 8 
unrestricted 8 
clearly 8 
Faced 8 
choice 8 
choose 8 
uncontrolled 8 
unsustainable 8 
pandemic.Even 8 
end-of-life 8 
exemption 8 
harmful 8 
Prognostication 8 
deteriorate 8 
suddenly 8 
usual 8 9 
occurences 8 
situation 8 
bedside 8 
sudden 8 
deterioration 8 
minimally 8 
responsive 8 
so-called 8 
quality 8 9 
Otani 8 
colleagues5 8 
complicated 8 
conversation 8 
eg 8 
able 8 
goodbye 8 
reduced 8 
depression 8 9 
grief.Limiting 8 
reasonable 8 
Considering 8 
cohabit 8 
occurs 8 
removal 8 
transit 8 
elevator 8 
cycling 8 
permit 8 
.We 8 
inconsistent 8 
problematic 8 
Patient 8 
transfer 8 
palliative 8 
receiving 8 
send 8 
alternate 8 
care.The 8 
broad 8 
Elements 8 
Munshi 8 
colleagues6 8 
relaxation 8 
proposal 8 
criticism 8 
rigid 8 
threat 8 
appreciate 8 9 
term.PanelProposed 8 
policy1The 8 
comfort 8 
coming 8 
consistently 8 
region.2Visitors 8 
circumstance 8 
hours.3The 8 
private 8 
semiprivate 8 
room.4Cycling 8 
wish 8 
advance 8 
ward.5Visitors 8 
proper 8 
Visitors 8 
unwilling 8 
comply 8 
virtual 8 
instead.6Although 8 
h 8 9 
rest.1The 8 
rest 8 
BackgroundThe 9 
associated 9 
severity.MethodsWe 9 
ambidirectional 9 
Yin-tan 9 
psychotic 9 
dementia 9 
re-admission 9 
osteoarthropathy 9 
immobile 9 
embolism 9 
welfare 9 
health-related 9 
6-min 9 
walking 9 
CT 9 
chest 9 
ultrasonography 9 
Enrolled 9 
Lopinavir 9 
Suppression 9 
Multivariable 9 
adjusted 9 
regression 9 
consequences.FindingsIn 9 
IQR 9 
Sept 9 
Fatigue 9 
muscle 9 
weakness 9 
Anxiety 9 
walk 9 
diffusion 9 
multivariable 9 
OR 9 
versus 9 
seropositivity 9 
vs 9 
titre 9 
neutralising 9 
glomerular 9 
filtration 9 
eGFR 9 
mL/min 9 
m2 9 
follow-up.InterpretationAt 9 
troubled 9 
impaired 9 
recovery.FundingNational 9 
Natural 9 
Academy 9 
Innovation 9 
Program 9 
Major 9 
Projects 9 
Creation 9 
Pulmonary 9 
Tuberculosis 9 
Foundation.The 9 
severity.We 9 
consequences.In 9 
follow-up.At 9 
recovery.National 9 
Foundation.• 9 
View 9 
content 9 
articleResearch 9 
contextEvidence 9 
studyWe 9 
PubMed 9 
Nov 9 
language 9 
2019-nCoV 9 
* 9 
sequela 9 
representativeness 9 
explicitness 9 
insufficient 9 
discharged 9 
unknown.Added 9 
studyTo 9 
n=1733 9 
Additionally 9 
abnormality 9 
Ground 9 
glass 9 
opacity 9 
irregular 9 
line 9 
N-IgM 9 
RBD-IgM 9 
S-IgM 9 
N-IgA 9 
RBD-IgA 9 
S-IgA 9 
RBD-IgG 9 
neutralise 9 
phase.Implications 9 
evidenceAt 9 
increasingly 9 
COVID-19.Evidence 9 
COVID-19.As 9 
COVID-19—an 9 
—has 9 
epidemiological 9 
described,1 9 
unclear.Long-term 9 
psychological 9 
urgently 9 
required.3 9 
hospital.4 9 
persisting 9 
dyspnoea,4 9 
function,5 9 
image 9 
abnormalities6 9 
spectrum 9 
post-discharge 9 
Furthermore 9 
extra-pulmonary 9 
discharge.We 9 
consequences.This 9 
designated 9 
Hubei 9 
attribute 9 
uniform 9 
guidance 9 
Commission 9 
consecutive 9 
obvious 9 
lesion 9 
.9The 9 
Ethics 9 
KY-2020–78.01 9 
Written 9 
participants.We 9 
retrieve 9 
education 9 
cigarette 9 
smoking 9 
self-reported 9 
comorbidities 9 
immunoglobulin 9 
antibiotic 9 
thymosin 9 
lopinavir–ritonavir 9 
arbidol 9 
phosphate 9 
,10 9 
resumption 9 
high-flow 9 
cannula 9 
HFNC 9 
non-invasive 9 
NIV 9 
IMV 9 
REDCap 9 
minimise 9 
input 9 
real-time 9 
control.The 9 
appointment 9 
reschedule 9 
visit.Follow-up 9 
consultation 9 
British 9 
mMRC 9 
dyspnoea 9 
EuroQol 9 
five-dimension 9 
five-level 9 
EQ-5D-5L 9 
Visual 9 
Analogue 9 
Scale 9 
EQ-VAS 9 
ischaemic 9 
registration 9 
form.11 9 
five-category 9 
dyspnoea.12 9 
validated 9 
mobility 9 
self-care 9 
pain 9 
discomfort 9 
Categorisation 9 
extreme 9 
problems.13 9 
subjective 9 
generic 9 
experience.14 9 
test.Venous 9 
creatinine 9 
haemoglobin 9 
glycated 9 
A1c 9 
HbA1c 9 
LOTUS 9 
.10 9 
Ig 9 
M 9 
nucleoprotein 9 
titred 9 
Vero 9 
microneutralisation 9 
studies.15 9 
disproportional 9 
limb 9 
vein 9 
abdomen 9 
HRCT 9 
≥5 9 
ultrasound 9 
Function 9 
Master 9 
Screen 9 
PFT 9 
Vyaire 9 
GmbH 9 
Hoechberg 9 
Thoracic 9 
Society 9 
guidelines.17 9 
Chest 9 
supine 9 
position 9 
end-inspiration 9 
SIEMENS 9 
SOMATOM 9 
PERSPECTIVE 9 
scanner 9 
Images 9 
reconstruct 9 
slice 9 
thickness 9 
increment 9 
× 9 
cross-compared 9 
experienced 9 
radiologist 9 
pulmonologist 9 
intelligence 9 
anatomic 9 
lobe 9 
lobe,18 9 
semi-quantitative 9 
involvement.19 9 
Briefly 9 
sum 9 
Estimated 9 
Chronic 9 
Kidney 9 
Disease-Epidemiology 9 
Collaboration 9 
Detailed 9 
thrombosis 9 
hair 9 
exercise 9 
min 9 
extrapulmonary 9 
ultrasonographic 9 
spleen 9 
pancreas 9 
seropositivity.Demographic 9 
categorise 9 
Demographic 9 
Mann-Whitney 9 
U 9 
χ2 9 
Fisher 9 
exact 9 
ORs 9 
CIs 9 
β 9 
Confounders 9 
never-smoker 9 
smoker 9 
former 9 
college 9 
middle 9 
comorbidity 9 
cerebrovascular 9 
malignant 9 
tumour 9 
paired 9 
McNemar 9 
seropositivity.Multivariable 9 
formula 9 
phase–CT 9 
/CT 9 
×100 9 
aforementioned 9 
impute 9 
funder 9 
interpretation 9 
submit 9 
publication.A 9 
outline 9 
exacerbation 9 
readmitted 9 
Finally 9 
sampled 9 
ascertain 9 
appointment.HRCT=high 9 
CT. 9 
LOTUS= 9 
†Laboratory 9 
lymphocyte 9 
glycosylated 9 
haemoglobin.The 9 
table 9 
enrolled 9 
non-IMV 9 
exclusively 9 
.Data 9 
n 9 
n/N 9 
denominator 9 
HFNC=high-flow 9 
NIV=non-invasive 9 
IMV=invasive 9 
NA=not 9 
ECMO=extracorporeal 9 
ICU=intensive 9 
unit.76 9 
Full 9 
v 9 
LLN 9 
specify 9 
OR=odds 9 
mMRC=modified 9 
EQ-5D-5L=EuroQol 9 
eGFR=estimated 9 
Quality 9 
worst 9 
imaginable 9 
.§ 9 
Predicted 9 
Enright 9 
Sherrill.22‖ 9 
subtract 9 
women.Data 9 
rate.390 9 
compliance 9 
Decreased 9 
FEV1=forced 9 
expiratory 9 
FVC=forced 9 
TLC=total 9 
FRC=functional 9 
residual 9 
RV=residual 9 
DLCO=diffusion 9 
carbon 9 
monoxide 9 
GGO=ground 9 
applicable.A 9 
p=0·0005 9 
p=0·028 9 
GGO 9 
consolidation 9 
Dynamic 9 
41-year-old 9 
Bilateral 9 
subpleural 9 
absorbed 9 
discharge.After 9 
Risk 9 
Age 9 
negatively 9 
10-year 9 
No 9 
observed.For 9 
ratio.Plasma 9 
trial10 9 
N-IgG 9 
S-IgG 9 
wan 9 
heterogeneous 9 
N 9 
Seropositivity 9 
y-axis 9 
Violin 9 
C 9 
D 9 
E 9 
horizontal 9 
OD=optical 9 
SARS-CoV-2=severe 9 
†p=0·29 9 
‡p=0·039 9 
§p=1·00 9 
¶p=0·021.The 9 
lymphocytopenia 9 
L 9 
abdominal 9 
non-acute 9 
presenting 9 
endorse 9 
phase.We 9 
Canadian 9 
decrement 9 
mental 9 
later.23 9 
SARS.24 9 
Female 9 
anxiety.25 9 
3-month 9 
Xiong 9 
colleagues8 9 
post-activity 9 
polypnoea 9 
alopecia 9 
mechanism 9 
psychiatric 9 
immunological 9 
stigma.26The 9 
considerable 9 
GGOs 9 
SARS27 9 
influenza.28 9 
induce 9 
fibroblast 9 
convalescence 9 
phase.29 9 
COVID-19.30 9 
radiological 9 
studies.In 9 
5-month 9 
timepoint.32 9 
compatible 9 
COVID-19.Our 9 
thromboembolic 9 
Angiotensin-converting 9 
proximal 9 
tubule34 9 
mediate 9 
epithelial 9 
cytotoxicity 9 
infiltration 9 
end-stage 9 
underestimation 9 
phase.37 9 
morbidity 9 
prevention.This 9 
Firstly 9 
unavailable 9 
fairly 9 
Secondly 9 
Thirdly 9 
Fangcang 9 
hospitals38 9 
SARS-CoV-2.At 9 
Longer 9 
COVID-19.ContributorsCW 9 
BC 9 
DZ 9 
JW 9 
YeW 9 
LR 9 
conceive 9 
LH 9 
XG 9 
GF 9 
LS 9 
JX 9 
LG 9 
GW 9 
revise 9 
intellectual 9 
CH 9 
LK 9 
XL 9 
XZ 9 
DC 9 
JL 9 
ZH 9 
ST 9 
YZ 9 
LC 9 
DX 9 
YaL 9 
CL 9 
LP 9 
YoL 9 
ML 9 
WX 9 
YiW 9 
JZ 9 
accountable 9 
appropriately 9 
investigated 9 
resolved.Declaration 9 
interestsWe 9 
interests.As 9 
dictionary 9 
field 9 
finish 9 
available.AcknowledgmentsThis 9 
CIFMS 9 
2020-I2M-CoV19–005 9 
Evergrande 9 
Jack 9 
Ma 9 
Sino 9 
Biopharmaceutical 9 
Ping 9 
Insurance 9 
Sunshine 9 
Charity 9 
Qiongya 9 
Ying 9 
Wen 9 
Geyi 9 
China-Japan 9 
Friendship 9 
design.Supplementary 9 
appendixLong-term 9 
